RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Coronary Disease
Accession: DOID:9000528
browse the term
Definition: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Synonyms: exact_synonym: CHD; Coronary Diseases; coronary heart disease; coronary heart diseases
narrow_synonym: CORONARY ARTERY DISEASE, EARLY-ONSET; THREE VESSEL CORONARY DISEASE; chronic coronary heart disease
related_synonym: CHDS1; CHDS2; CHDS3; CHDS4; CHDS5; CHDS6; CHDS7; CHDS8; CHDS9; CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1; CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 2; CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 3; CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 4; CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5; CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 8; CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 9; Coronary artery disease, susceptibility to; Coronary heart disease in familial hypercholesterolemia, protection against
primary_id: MESH:D003327
alt_id: OMIM:300464 ; OMIM:607339 ; OMIM:608316 ; OMIM:608318 ; OMIM:608901 ; OMIM:610938 ; OMIM:611139 ; OMIM:612030 ; OMIM:614466
G
ABCA1
ATP binding cassette subfamily A member 1
IAGP
ClinVar Annotator: match by term: Early-onset coronary artery disease
ClinVar
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCG5
ATP binding cassette subfamily G member 5
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Early-onset coronary artery disease
CTD ClinVar
PMID:19060911
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
G
ABCG8
ATP binding cassette subfamily G member 8
IAGP
ClinVar Annotator: match by term: Early-onset coronary artery disease
ClinVar
NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
IAGP
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
G
ACE
angiotensin I converting enzyme
susceptibility
IAGP EXP
DNA:deletion:intron:IVS16+1464-1751del (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8170965 PMID:9488209
RGD:8142364
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACE2
angiotensin converting enzyme 2
susceptibility
IAGP
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphism: :8790G>A (human)
RGD
PMID:18753062
RGD:2313798
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ADA
adenosine deaminase
IEP
protein:increased expression:leukocyte
RGD
PMID:17259686
RGD:1624286
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
G
ADAMTS13
ADAM metallopeptidase with thrombospondin type 1 motif 13
IEP IAGP
protein:decreased activity:plasma (human) ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar RGD
PMID:25741868 PMID:28492532 PMID:12670342
RGD:10449044
NCBI chr 9:133,414,337...133,459,386
Ensembl chr 9:133,414,358...133,459,402
G
ADAMTS7
ADAM metallopeptidase with thrombospondin type 1 motif 7
IAGP
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
NCBI chr15:78,759,206...78,811,464
Ensembl chr15:78,759,206...78,811,464
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
disease_progression
IEP
associated with Diabetes mellitus, Type2;
RGD
PMID:22207678 PMID:22019747
RGD:5686379 , RGD:5686406
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADRB2
adrenoceptor beta 2
susceptibility
IAGP
DNA:polymorphism: :p.Q27E
RGD
PMID:12682000
RGD:1601128
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
G
ADRB3
adrenoceptor beta 3
susceptibility
IAGP IEA
associated with Diabetes Mellitus, Type 2; DNA:missense mutation:cds:p.W64R rs4994(human)
RGD GAD
PMID:10421225 PMID:20536507 PMID:15118671
RGD:1559326 , RGD:5684776 , RGD:1331525
NCBI chr 8:37,962,990...37,966,599
Ensembl chr 8:37,962,990...37,966,599
G
AGER
advanced glycosylation end-product specific receptor
susceptibility
IEP
protein:decreased expression:plasma (human) associated with Heart Failure; protein:increased expression:plasma (human)
RGD
PMID:23396398 PMID:20685687
RGD:7243186 , RGD:7244134
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AGTR1
angiotensin II receptor type 1
susceptibility no_association
IAGP
DNA:polymorphism:3' utr:1166A>C DNA:polymorphism:3' utr:1166A>C (human)
RGD
PMID:9456365 PMID:9857918
RGD:1601152 , RGD:1566499
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AGXT2
alanine--glyoxylate aminotransferase 2
IAGP
DNA:missense mutation:cds:V140I (rs37369)(human)
RGD
PMID:24834905
RGD:329961320
NCBI chr 5:34,998,102...35,047,949
Ensembl chr 5:34,998,101...35,048,135
G
APOA4
apolipoprotein A4
susceptibility no_association
IAGP
DNA:missense mutation:cds:p.T347S (human)
RGD
PMID:12676816 PMID:9013087
RGD:1578411 , RGD:5685683
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
APOB
apolipoprotein B
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Early-onset coronary artery disease
CTD ClinVar
PMID:17658632
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
G
APOC2
apolipoprotein C2
susceptibility
IAGP
RGD
PMID:7590197
RGD:1601205
NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565
G
APOC3
apolipoprotein C3
susceptibility no_association
IAGP
associated with Diabetes Mellitus, Non-Insulin-Dependent ClinVar Annotator: match by term: Coronary heart disease DNA:polymorphism:promoter:-482C>T
ClinVar RGD
PMID:11060345 PMID:19074352 PMID:20097930 PMID:23701270 PMID:24941081 PMID:24941082 PMID:25225788 PMID:25962519 PMID:27114411 PMID:28406212 PMID:28492532 PMID:28825717 PMID:29237685 PMID:30255797 PMID:32041611 PMID:34548093 PMID:36876364 PMID:17654446 PMID:16321685 More...
RGD:2306754 , RGD:1601224
NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
G
APOE
apolipoprotein E
onset
IAGP EXP
DNA:polymorphisms, haplotype:promoter, cds:g.-219G>T, p.C112R, p.R158C (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10736278 PMID:11862316
RGD:1578479
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
CCDC92
coiled-coil domain containing 92
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr12:123,935,626...123,972,831
Ensembl chr12:123,918,660...123,972,831
G
CCR5
C-C motif chemokine receptor 5
resistance
IAGP
DNA:polymorphisms:multiple (human)
RGD
PMID:16055130
RGD:1581176
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CD14
CD14 molecule
IEP
protein:increased expression:monocyte
RGD
PMID:10831941
RGD:2314175
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD36
CD36 molecule (CD36 blood group)
susceptibility
IEP IAGP EXP
mRNA:increased expression:monocyte ClinVar Annotator: match by term: CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:25741868 PMID:28960434 PMID:33116287 PMID:18067591
RGD:6893507
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD40LG
CD40 ligand
treatment
ISO
RGD
PMID:23819214
RGD:7248750
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
G
CDKN2B
cyclin dependent kinase inhibitor 2B
IAGP
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
G
CDKN2B-AS1
CDKN2B antisense RNA 1
IAGP
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
NCBI chr 9:21,994,791...22,128,142
Ensembl chr 9:21,994,139...22,128,103
G
CETP
cholesteryl ester transfer protein
susceptibility
ISO IAGP
DNA:SNP: G>A (rs4783961) in younger than 55 years of age
RGD
PMID:10861897 PMID:29848931
RGD:1580358 , RGD:401799677
NCBI chr16:56,961,950...56,983,845
Ensembl chr16:56,961,923...56,983,845
G
CX3CR1
C-X3-C motif chemokine receptor 1
IAGP EXP
DNA:polymorphism: :p.V249I (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 1
CTD OMIM ClinVar RGD
PMID:25741868 PMID:11532900
RGD:4891901
NCBI chr 3:39,263,494...39,292,966
Ensembl chr 3:39,263,495...39,281,735
G
CYBA
cytochrome b-245 alpha chain
IAGP
RGD
PMID:10488959
RGD:1580275
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
G
CYP2J2
cytochrome P450 family 2 subfamily J member 2
resistance
IAGP
DNA:polymorphism:promoter:-50G>T (human)
RGD
PMID:17429317
RGD:1625377
NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,773
G
DAB2IP
DAB2 interacting protein
IAGP
DNA:SNP:CDS:rs7025486 (human)
RGD
PMID:21444365
RGD:401938618
NCBI chr 9:121,567,074...121,785,530
Ensembl chr 9:121,567,057...121,785,530
G
DNAH11
dynein axonemal heavy chain 11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19060911
NCBI chr 7:21,543,039...21,901,839
Ensembl chr 7:21,543,039...21,901,839
G
EPHX2
epoxide hydrolase 2
IAGP
RGD
PMID:16595607
RGD:1580981
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
ESR2
estrogen receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17367797
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
G
F12
coagulation factor XII
IEP
protein:decreased activity::
RGD
PMID:18021303
RGD:11041785
NCBI chr 5:177,402,141...177,409,564
Ensembl chr 5:177,402,133...177,416,583
G
F13A1
coagulation factor XIII A chain
IAGP
RGD
PMID:11391716
RGD:1581030
NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013
G
FGF2
fibroblast growth factor 2
IEP
associated with Diabetes Mellitus
RGD
PMID:15451784
RGD:2315870
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
FLT1
fms related receptor tyrosine kinase 1
IEP
mRNA, protein:increased expression:ventricle myocardium
RGD
PMID:16139132
RGD:2313728
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
IAGP
DNA:SNP: :rs9939609 (human)
RGD
PMID:26555680
RGD:11555922
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
G
GGT1
gamma-glutamyltransferase 1
IEP
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:serum
RGD
PMID:16772340
RGD:2315604
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GLUL
glutamate-ammonia ligase
IAGP
associated with type 2 diabetes mellitus;DNA:SNP: :rs10911021 (human)
RGD
PMID:23982368
RGD:401794410
NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206
G
GP1BA
glycoprotein Ib platelet subunit alpha
IAGP
RGD
PMID:14592833
RGD:1580433
NCBI chr17:4,932,277...4,935,023
Ensembl chr17:4,932,277...4,935,023
G
GP6
glycoprotein VI platelet
treatment exacerbates
IGI IEP IDA
protein:increased expression:venous blood, platelet (human) DNA:hypomethylation:promoter
RGD
PMID:17105818 PMID:20049463 PMID:31783053
RGD:401794440 , RGD:401824649 , RGD:401824645
NCBI chr19:55,013,705...55,038,264
Ensembl chr19:55,013,705...55,038,264
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
disease_progression
IMP
RGD
PMID:15809366
RGD:5508474
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMOX1
heme oxygenase 1
IEP
RGD
PMID:15869055
RGD:1598404
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNF1A
HNF1 homeobox A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr12:120,978,543...121,002,512
Ensembl chr12:120,978,543...121,002,512
G
HP
haptoglobin
severity
IEP
RGD
PMID:16673012
RGD:1626344
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
IAGP
DNA:SNPs: : -110A>C (rs1008438), 190G>C (rs1043618) (human)
RGD
PMID:19333379
RGD:7257652
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPD1
heat shock protein family D (Hsp60) member 1
IDA
RGD
PMID:12059985
RGD:1624217
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
IGF1
insulin like growth factor 1
IDA
RGD
PMID:15521962
RGD:1626121
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGFALS
insulin like growth factor binding protein acid labile subunit
IDA
RGD
PMID:15521962
RGD:1626121
NCBI chr16:1,790,413...1,794,908
Ensembl chr16:1,790,413...1,794,971
G
IGFBP3
insulin like growth factor binding protein 3
IDA
RGD
PMID:15521962
RGD:1626121
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
IGFBP5
insulin like growth factor binding protein 5
IDA
RGD
PMID:15521962
RGD:1626121
NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
G
IL18
interleukin 18
IAGP
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1B
interleukin 1 beta
IAGP
DNA:polymorphism
RGD
PMID:15379752
RGD:1626636
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IRF8
interferon regulatory factor 8
susceptibility
IAGP
DNA:SNPs:intron 4, intron 2: (rs925994,rs10514610) (human)
RGD
PMID:23661672
RGD:329902076
NCBI chr16:85,899,162...85,922,609
Ensembl chr16:85,899,116...85,922,606
G
IRS1
insulin receptor substrate 1
IAGP EXP
ClinVar Annotator: match by term: Coronary artery disease, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:1311924 PMID:7623569 PMID:8104271 PMID:8647950 PMID:10084586 PMID:10430617 PMID:10591678 PMID:10843189 PMID:12843189 PMID:14671192 PMID:14707024 PMID:15240653 PMID:28869590 More...
NCBI chr 2:226,731,312...226,799,820
Ensembl chr 2:226,731,312...226,799,820
G
ITGA2
integrin subunit alpha 2
no_association
IAGP
RGD
PMID:9684730
RGD:1582306
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
ITGAM
integrin subunit alpha M
exacerbates
IEP
protein:increased expression:monocyte (human)
RGD
PMID:20876457
RGD:329901842
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
ITGB3
integrin subunit beta 3
IAGP
DNA:polymorphism:exon
RGD
PMID:10583927
RGD:5128478
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
G
KALRN
kalirin RhoGEF kinase
IAGP
ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 5
ClinVar
PMID:17357071 PMID:25741868
NCBI chr 3:124,033,369...124,726,325
Ensembl chr 3:124,033,369...124,726,325
G
KAT2B
lysine acetyltransferase 2B
severity
IAGP
DNA:snp:promoter:g.-2481G>C (human)
RGD
PMID:21062767
RGD:9590309
NCBI chr 3:20,040,446...20,154,404
Ensembl chr 3:20,040,446...20,154,404
G
KCNJ8
potassium inwardly rectifying channel subfamily J member 8
no_association
IAGP
RGD
PMID:12964027
RGD:1581699
NCBI chr12:21,764,955...21,774,706
Ensembl chr12:21,764,955...21,775,600
G
KDR
kinase insert domain receptor
IEP
mRNA, protein:increased expression:ventricle myocardium
RGD
PMID:16139132
RGD:2313728
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
LDLR
low density lipoprotein receptor
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Early-onset coronary artery disease
CTD ClinVar
PMID:9430375 PMID:9712531 PMID:10422804 PMID:11810272 PMID:11845603 PMID:17765246 PMID:19318025 PMID:20506408 PMID:21382890 PMID:21642693 PMID:22390909 PMID:23375686 PMID:24033266 PMID:25487149 PMID:25647241 PMID:25741868 PMID:28161202 PMID:28492532 PMID:28895539 PMID:29353225 PMID:30293936 PMID:30637778 PMID:30971288 PMID:32719484 PMID:33418990 PMID:33454241 PMID:33740630 PMID:34037665 PMID:35339733 PMID:35568682 PMID:36499307 More...
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LDLR-AS1
LDLR antisense RNA 1
IAGP
ClinVar Annotator: match by term: Early-onset coronary artery disease
ClinVar
PMID:25741868
NCBI chr19:11,089,068...11,089,659
G
LEPR
leptin receptor
onset
IAGP
DNA:SNP: C>T (rs6656451) (human)
RGD
PMID:29848931
RGD:401799677
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
LGALS2
galectin 2
susceptibility
IAGP
RGD
PMID:17040205
RGD:1581853
NCBI chr22:37,570,248...37,580,087
Ensembl chr22:37,570,248...37,582,616
G
LIPC
lipase C, hepatic type
susceptibility
IAGP
associated with Obesity and Diabetes; DNA:transition:promoter:-514C>T (human)
RGD
PMID:16570154
RGD:2308824
NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
G
LOC110806263
TERT 5' regulatory region
IAGP
ClinVar Annotator: match by term: Coronary artery disease, susceptibility to
ClinVar
PMID:16890917
NCBI chr 5:1,294,628...1,298,988
G
LOC112679198
ABO +5.8 intron 1 enhancer
IAGP
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
NCBI chr 9:133,267,998...133,270,594
G
LOC126860596
BRD4-independent group 4 enhancer GRCh37_chr9:22102887-22104086
IAGP
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
NCBI chr 9:22,102,608...22,104,087
G
LPA
lipoprotein(a)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:10484779
NCBI chr 6:160,531,482...160,664,275
Ensembl chr 6:160,531,482...160,664,275
G
LPL
lipoprotein lipase
ISO IAGP
ClinVar Annotator: match by term: Coronary heart disease
ClinVar RGD
PMID:8199176 PMID:8541837 PMID:8872057 PMID:10364086 PMID:10517255 PMID:21146168 PMID:24033266 PMID:25741868 PMID:28492532 PMID:27000070 More...
RGD:13794381
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
LRP1
LDL receptor related protein 1
susceptibility
IAGP
RGD
PMID:15121769
RGD:1581911
NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361
G
MACO1
macoilin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19060911
NCBI chr 1:25,430,897...25,500,209
Ensembl chr 1:25,430,858...25,500,209
G
MB
myoglobin
severity
IDA
RGD
PMID:15976963
RGD:1582388
NCBI chr22:35,606,764...35,623,354
Ensembl chr22:35,606,764...35,637,951
G
MGP
matrix Gla protein
susceptibility
IDA
RGD
PMID:16973975
RGD:1582502
NCBI chr12:14,880,864...14,885,854
Ensembl chr12:14,880,864...14,885,857
G
MIF
macrophage migration inhibitory factor
ISO
coronary occlusion; mRNA:increased expression:myocardium
RGD
PMID:20367970
RGD:4890973
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MIR17HG
miR-17-92a-1 cluster host gene
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr13:91,347,820...91,354,575
Ensembl chr13:91,347,686...91,397,592
G
MLXIP
MLX interacting protein
susceptibility
IAGP
DNA:SNP:3'utr: (rs4758685) (human)
RGD
PMID:23840567
RGD:401794443
NCBI chr12:122,078,756...122,147,344
Ensembl chr12:122,078,756...122,147,344
G
MLXIPL
MLX interacting protein like
susceptibility
IAGP
DNA:SNP: (rs35493868); in younger than 55 years of age
RGD
PMID:29848931
RGD:401799677
NCBI chr 7:73,593,202...73,647,907
Ensembl chr 7:73,593,194...73,624,543
G
MMP1
matrix metallopeptidase 1
susceptibility
IAGP
DNA:insertion:promoter:g.-1607insG (human)
RGD
PMID:14499230
RGD:1582537
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP3
matrix metallopeptidase 3
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 6 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:7727178 PMID:8662692 PMID:9699891 PMID:10190398 PMID:10351963 PMID:12477941 PMID:12485468 More...
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MRAS
muscle RAS oncogene homolog
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr 3:138,347,648...138,405,535
Ensembl chr 3:138,347,648...138,405,534
G
MTHFR
methylenetetrahydrofolate reductase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16792904
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
MTTP
microsomal triglyceride transfer protein
susceptibility
IAGP
DNA:polymorphism:promoter:-493G>T
RGD
PMID:15136504
RGD:1625487
NCBI chr 4:99,564,130...99,623,997
Ensembl chr 4:99,564,081...99,623,997
G
MYH15
myosin heavy chain 15
IAGP
DNA:snp:exon:EX28T>C rs3900940 (human)
RGD
PMID:18073581
RGD:2317145
NCBI chr 3:108,380,368...108,551,072
Ensembl chr 3:108,380,368...108,529,322
G
NR1H3
nuclear receptor subfamily 1 group H member 3
exacerbates
IEP
mRNA:decreased expression:peripheral blood mononuclear cell (human) mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:16252156 PMID:19211025
RGD:401827902 , RGD:401850788
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
OAZ1
ornithine decarboxylase antizyme 1
susceptibility
IAGP
DNA:SNP:intron:c.2222A>G (rs2074458) (human)
RGD
PMID:17761941
RGD:401851037
NCBI chr19:2,269,486...2,273,488
Ensembl chr19:2,269,509...2,273,490
G
PCSK9
proprotein convertase subtilisin/kexin type 9
susceptibility
IAGP
DNA:missense mutation, nonsense mutations:cds:p.R46L, p.Y142X, p.C679X (human)
RGD
PMID:16554528
RGD:1581000
NCBI chr 1:55,039,548...55,064,852
Ensembl chr 1:55,039,447...55,064,852
G
PECAM1
platelet and endothelial cell adhesion molecule 1
IAGP
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
PMID:8532023
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PHACTR1
phosphatase and actin regulator 1
no_association susceptibility
IAGP
DNA:SNP:intron 3: (rs12526453) (human) associated with type 2 diabetes mellitus;DNA:SNP:intron: (rs12526453) (human)
RGD
PMID:28287809 PMID:22152955
RGD:401901081 , RGD:11055500
NCBI chr 6:12,716,767...13,287,837
Ensembl chr 6:12,716,312...13,290,446
G
PLA2G7
phospholipase A2 group VII
IEP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21356620 PMID:15699277
RGD:6482780
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
PLAU
plasminogen activator, urokinase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:1730212 PMID:9181759
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PLTP
phospholipid transfer protein
susceptibility
IEP
protein:increased expression:serum (human)
RGD
PMID:14695459
RGD:1581038
NCBI chr20:45,898,620...45,912,155
Ensembl chr20:45,898,621...45,912,155
G
PON1
paraoxonase 1
no_association severity
IAGP EXP IEP
associated with Diabetes Mellitus, Type 2;DNA:missense mutation:cds:p.Q192R (human) ClinVar Annotator: match by term: Coronary artery disease, susceptibility to CTD Direct Evidence: marker/mechanism protein:decreased expression:serum
ClinVar CTD RGD
PMID:7916578 PMID:8098250 PMID:8675673 PMID:8770857 PMID:9011577 PMID:9215303 PMID:9385372 PMID:9443884 PMID:9661650 PMID:11238489 PMID:11335891 PMID:11788650 PMID:11810302 PMID:11888590 PMID:11889198 PMID:11918623 PMID:12082503 PMID:15241482 PMID:16353344 PMID:16882531 PMID:21170047 PMID:25741868 PMID:9215303 PMID:15214960 PMID:19005291 More...
RGD:1580201 , RGD:8547675 , RGD:2313267
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
PON2
paraoxonase 2
susceptibility
IAGP
DNA:missense mutation:cds:p.C311S (human)
RGD
PMID:9443862
RGD:1580216
NCBI chr 7:95,404,862...95,435,028
Ensembl chr 7:95,404,862...95,435,329
G
PPBP
pro-platelet basic protein
IEP
associated with menopause; mRNA,protein:increased expression:peripheral blood mononuclear cell ,plasma
RGD
PMID:35734636
RGD:401794436
NCBI chr 4:73,986,439...73,988,190
Ensembl chr 4:73,986,439...73,988,190
G
RBP4
retinol binding protein 4
IEP
protein:increased expression:blood plasma (human)
RGD
PMID:23584360
RGD:329845574
NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744
G
RETN
resistin
IEP
protein:increased expression:blood
RGD
PMID:17175295
RGD:7207156
NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455
G
RTEL1
regulator of telomere elongation helicase 1
ameliorates
IAGP
DNA:SNP:cds:rs6010620|rs4809324 (human)
RGD
PMID:30623606
RGD:152985693
NCBI chr20:63,657,810...63,696,253
Ensembl chr20:63,657,810...63,696,253
G
SCARB1
scavenger receptor class B member 1
ISO
RGD
PMID:15967843
RGD:1580004
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SELP
selectin P
IEP
protein:altered expression:serum
RGD
PMID:11597943
RGD:1580074
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
SERPINF2
serpin family F member 2
IEP
protein:increased expression:blood
RGD
PMID:15771120
RGD:1625529
NCBI chr17:1,742,871...1,755,265
Ensembl chr17:1,742,836...1,755,265
G
TCF7L2
transcription factor 7 like 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr10:112,950,247...113,167,678
Ensembl chr10:112,950,247...113,167,678
G
TERT
telomerase reverse transcriptase
IAGP
ClinVar Annotator: match by term: Coronary artery disease, susceptibility to
ClinVar
PMID:16890917
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
THBD
thrombomodulin
IEP
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:plasma
RGD
PMID:17200788
RGD:2312456
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
VEGFA
vascular endothelial growth factor A
IEP
mRNA, protein:increased expression:ventricle myocardium
RGD
PMID:16139132
RGD:2313728
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VKORC1
vitamin K epoxide reductase complex subunit 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16549638
NCBI chr16:31,090,854...31,094,797
Ensembl chr16:31,090,842...31,095,980
G
VWF
von Willebrand factor
IEP
RGD
PMID:11864703
RGD:1580647
NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770
G
ZC3HC1
zinc finger C3HC-type containing 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr 7:130,018,286...130,051,451
Ensembl chr 7:130,018,287...130,051,451
G
ARHGAP17
Rho GTPase activating protein 17
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr16:24,919,389...25,015,369
Ensembl chr16:24,919,389...25,015,666
G
BAX
BCL2 associated X, apoptosis regulator
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
C3
complement C3
IEP
RGD
PMID:26476955
RGD:11552746
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CACNG4
calcium voltage-gated channel auxiliary subunit gamma 4
IEP
mRNA:decreased expression:blood:
RGD
PMID:27746059
RGD:13524557
NCBI chr17:66,964,707...67,033,398
Ensembl chr17:66,964,707...67,033,398
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:26550220
RGD:13782284
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP7
caspase 7
treatment
ISO
RGD
PMID:26550220
RGD:13782284
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
G
CCN1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:30371213
RGD:329845516
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
DSC2
desmocollin 2
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,840...31,102,522
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
HEP
mRNA:increased expression:blood
RGD
PMID:35693610
RGD:329901852
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
G
GATA5
GATA binding protein 5
susceptibility
IAGP
DNA:SNPs:promoter:rs80197101, rs77067995 (human)
RGD
PMID:33684162
RGD:155260335
NCBI chr20:62,463,497...62,475,995
Ensembl chr20:62,463,497...62,475,995
G
GP6
glycoprotein VI platelet
ameliorates sexual_dimorphism
IAGP
DNA:missense mutation:CDS:p.S219P (rs1613662) (human) DNA:missense mutation:intron 1, intron 5: (rs1671207, rs11084382) (human)
RGD
PMID:20227257 PMID:20227257
RGD:401794138 , RGD:401794138
NCBI chr19:55,013,705...55,038,264
Ensembl chr19:55,013,705...55,038,264
G
GPX3
glutathione peroxidase 3
IEP
protein:increased expression:plasma
RGD
PMID:28374671
RGD:401827832
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
GSK3B
glycogen synthase kinase 3 beta
treatment ameliorates
ISO
RGD
PMID:26591365 PMID:32068187
RGD:13792778 , RGD:267358468
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
H19
H19 imprinted maternally expressed transcript
ameliorates
ISO
RGD
PMID:31755219
RGD:213230161
NCBI chr11:1,995,176...2,001,466
Ensembl chr11:1,995,166...2,004,552
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
IAGP
ClinVar Annotator: match by term: Acute myocardial infarction
ClinVar
PMID:20946881 PMID:21250968 PMID:21596855 PMID:21997850 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22616558 PMID:22898539 PMID:23949315 PMID:24606448 PMID:25157968 PMID:26619011 More...
NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
G
IFNG
interferon gamma
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046
G
IL10
interleukin 10
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL17A
interleukin 17A
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL1B
interleukin 1 beta
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
ISO
RGD
PMID:24837094
RGD:40813741
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL33
interleukin 33
ISO
RGD
PMID:24837094
RGD:40813741
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
IL4
interleukin 4
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6
interleukin 6
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
ITGAM
integrin subunit alpha M
treatment
IEP
RGD
PMID:21238619
RGD:329901664
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
KIF6
kinesin family member 6
IAGP
DNA:SNP: :p.W719R (rs20455) (human)
RGD
PMID:20044086
RGD:243048455
NCBI chr 6:39,329,990...39,725,408
Ensembl chr 6:39,329,990...39,725,408
G
MALAT1
metastasis associated lung adenocarcinoma transcript 1
ameliorates
ISO
RGD
PMID:29990866
RGD:155882565
NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,640...65,508,073
G
MIR126
microRNA 126
disease_progression
IEP
RGD
PMID:36523365 PMID:32595526
RGD:401851047 , RGD:401851053
NCBI chr 9:136,670,602...136,670,686
Ensembl chr 9:136,670,602...136,670,686
G
MIR146A
microRNA 146a
IEP
miRNA:increased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
G
MIR155
microRNA 155
IEP
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR17
microRNA 17
treatment
ISO
RGD
PMID:29536180
RGD:329403057
NCBI chr13:91,350,605...91,350,688
Ensembl chr13:91,350,605...91,350,688
G
MIR21
microRNA 21
IEP
miRNA:increased expression:peripheral blood mononuclear cell, plasma RNA:decreased expression:serum
RGD
PMID:31866771 PMID:32595526
RGD:21081515 , RGD:401851053
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
G
MIR223
microRNA 223
treatment
ISO
RGD
PMID:29689569
RGD:25823140
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
MIR320A
microRNA 320a
ISO
RGD
PMID:29990866
RGD:155882565
NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043
G
MT-CO2
mitochondrially encoded cytochrome c oxidase II
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr MT:7,586...8,269
Ensembl chr MT:7,586...8,269
G
NDUFB5
NADH:ubiquinone oxidoreductase subunit B5
ameliorates
ISO
associated with obesity
RGD
PMID:35257523
RGD:401794445
NCBI chr 3:179,604,794...179,627,647
Ensembl chr 3:179,604,690...179,627,647
G
PF4
platelet factor 4
treatment
ISO
RGD
PMID:29407168
RGD:329901925
NCBI chr 4:73,980,811...73,982,124
Ensembl chr 4:73,980,811...73,982,027
G
PLCG1
phospholipase C gamma 1
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
G
PPBP
pro-platelet basic protein
treatment
ISO
RGD
PMID:29407168
RGD:329901925
NCBI chr 4:73,986,439...73,988,190
Ensembl chr 4:73,986,439...73,988,190
G
PTEN
phosphatase and tensin homolog
ameliorates
ISO IEP
mRNA:decreased expression:heart left ventricle (rat) RNA:increased expression:serum
RGD
PMID:26973267 PMID:32595526 PMID:29990866
RGD:11526378 , RGD:401851053 , RGD:155882565
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
RHOA
ras homolog family member A
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
RIT2
Ras like without CAAX 2
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr18:42,743,227...43,115,685
Ensembl chr18:42,743,227...43,115,691
G
SDHB
succinate dehydrogenase complex iron sulfur subunit B
ameliorates
ISO
associated with obesity
RGD
PMID:35257523
RGD:401794445
NCBI chr 1:17,018,722...17,054,032
Ensembl chr 1:17,018,664...17,054,032
G
SERPING1
serpin family G member 1
IEP ISO
mRNA:increased expression:heart
RGD
PMID:26476955 PMID:26476955
RGD:11552746 , RGD:11552746
NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
G
TBX1
T-box transcription factor 1
treatment
ISO
RGD
PMID:27422448
RGD:155882497
NCBI chr22:19,756,703...19,783,593
Ensembl chr22:19,756,703...19,783,593
G
TNF
tumor necrosis factor
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
ZEB1
zinc finger E-box binding homeobox 1
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr10:31,318,417...31,529,804
Ensembl chr10:31,318,495...31,529,814
G
EDN1
endothelin 1
IEP
protein:increased expression:aortic root, coronary sinus, plasma (human)
RGD
PMID:12581682
RGD:8661757
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
SERPINE1
serpin family E member 1
disease_progression
ISO
protein:decreased expression, decreased activity:heart:
RGD
PMID:12615902 PMID:12615902
RGD:13208541 , RGD:13208541
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
F3
coagulation factor III, tissue factor
ISO
RGD
PMID:9916935
RGD:11341701
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
HNRNPK
heterogeneous nuclear ribonucleoprotein K
IDA
RGD
PMID:21489814
RGD:155260371
NCBI chr 9:83,968,083...83,980,615
Ensembl chr 9:83,968,083...83,980,631
G
PDGFD
platelet derived growth factor D
IDA
RGD
PMID:19213942
RGD:9854642
NCBI chr11:103,907,189...104,164,147
Ensembl chr11:103,907,189...104,164,379
G
EPO
erythropoietin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19337937
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
G
PLAT
plasminogen activator, tissue type
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:1430592
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
SOD2
superoxide dismutase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21062213
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
IEP
associated with Mucocutaneous Lymph Node Syndrome;protein:increased expression:serum
RGD
PMID:22683371
RGD:8694456
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
GJA1
gap junction protein alpha 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15548583
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
ITPKC
inositol-trisphosphate 3-kinase C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18084290
NCBI chr19:40,717,112...40,740,860
Ensembl chr19:40,717,112...40,740,860
G
MICA
MHC class I polypeptide-related sequence A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:10899738
NCBI chr 6:31,400,711...31,415,315
Ensembl chr 6:31,399,784...31,415,315
G
MMP12
matrix metallopeptidase 12
susceptibility
IAGP
RGD
PMID:12103254
RGD:1582363
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
G
ABCA1
ATP binding cassette subfamily A member 1
IAGP IEA
RGD GAD
PMID:11086027 PMID:15118671
RGD:1600951 , RGD:1331525
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCC6
ATP binding cassette subfamily C member 6
IAGP
DNA:nonsense mutation:exon:p.R1141X (3421C>T) (human)
RGD
PMID:12176944
RGD:11038788
NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,522
G
ABCG5
ATP binding cassette subfamily G member 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11099417 PMID:11138003
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
G
ABCG8
ATP binding cassette subfamily G member 8
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
CTD ClinVar
PMID:11099417 PMID:25741868
NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
G
ACAT2
acetyl-CoA acetyltransferase 2
susceptibility
IAGP
DNA:polymorphisms: :41A>G, 734C>T, IVS4-57_58ins48bp
RGD
PMID:16195894
RGD:1601112
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
G
ACE
angiotensin I converting enzyme
susceptibility
IAGP EXP IEA
DNA:deletion:intron:IVS16+1464-1751del (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14989558 PMID:12975417 PMID:15118671
RGD:1566498 , RGD:1331525
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACP1
acid phosphatase 1
IAGP
RGD
PMID:19246900
RGD:2313179
NCBI chr 2:264,947...278,283
Ensembl chr 2:264,140...278,283
G
ADAMTS7
ADAM metallopeptidase with thrombospondin type 1 motif 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr15:78,759,206...78,811,464
Ensembl chr15:78,759,206...78,811,464
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
susceptibility
IEP IAGP
protein:decreased expression:adipose tissue associated with type 2 diabetes mellitus; DNA:SNP: (rs2241766) +45T>G(human)
RGD
PMID:17878891 PMID:27218147
RGD:5686802 , RGD:329956419
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADRB3
adrenoceptor beta 3
no_association
IAGP
DNA:missense mutation:cds:p.W64R (human) DNA:missense mutation:cds:p.W64R rs4994 (human)
RGD
PMID:9126344 PMID:11229427
RGD:1559325 , RGD:5684412
NCBI chr 8:37,962,990...37,966,599
Ensembl chr 8:37,962,990...37,966,599
G
ADTRP
androgen dependent TFPI regulating protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378986
NCBI chr 6:11,713,523...11,778,803
Ensembl chr 6:11,712,054...11,807,046
G
AGER
advanced glycosylation end-product specific receptor
susceptibility
IAGP IEP
DNA:polymorphism:cds:p.G82S (human) associated with Mucocutaneous Lymph Node Syndrome
RGD
PMID:20668462 PMID:22337222
RGD:6767569 , RGD:8695960
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AGT
angiotensinogen
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AGTR1
angiotensin II receptor type 1
IAGP IEA
RGD GAD
PMID:12975417 PMID:15118671
RGD:1566498 , RGD:1331525
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AGXT2
alanine--glyoxylate aminotransferase 2
IAGP
DNA:missense mutation:cds:rs37369, rs16899974 (human)
RGD
PMID:30284143
RGD:329961317
NCBI chr 5:34,998,102...35,047,949
Ensembl chr 5:34,998,101...35,048,135
G
AHSG
alpha 2-HS glycoprotein
susceptibility
IAGP
associated with Diabetes Mellitus, Type 2;DNA:SNPs
RGD
PMID:17062776
RGD:1625792
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
G
AKT1
AKT serine/threonine kinase 1
ISO
RGD
PMID:18054314
RGD:5509083
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
IAGP
DNA:snps:multiple (human)
RGD
PMID:19596330
RGD:2313883
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
G
AMPD1
adenosine monophosphate deaminase 1
susceptibility
IAGP
DNA:SNP:exon 2:34C>T (human) DNA:SNP:exon:34C>T (human)
RGD
PMID:11028479 PMID:24508110
RGD:329349360 , RGD:329412480
NCBI chr 1:114,673,098...114,695,546
Ensembl chr 1:114,673,090...114,695,618
G
ANGPTL4
angiopoietin like 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27135400
NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370
G
ANKS1A
ankyrin repeat and sterile alpha motif domain containing 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 6:34,889,255...35,097,990
Ensembl chr 6:34,889,255...35,091,406
G
APCS
amyloid P component, serum
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12714198
NCBI chr 1:159,587,826...159,588,865
Ensembl chr 1:159,587,826...159,588,865
G
APH1B
aph-1 homolog B, gamma-secretase subunit
IAGP
DNA:SNP:CDS:p.F217L (rs1047552) (human)
RGD
PMID:18987747
RGD:13703124
NCBI chr15:63,277,605...63,309,126
Ensembl chr15:63,276,018...63,309,126
G
APOA1
apolipoprotein A1
IEP EXP IEA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27135400 PMID:2128269 PMID:15118671
RGD:1601188 , RGD:1331525
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
G
APOA2
apolipoprotein A2
IEP
protein:decreased expression:serum
RGD
PMID:17923573
RGD:2313956
NCBI chr 1:161,222,292...161,223,628
Ensembl chr 1:161,222,292...161,223,631
G
APOA5
apolipoprotein A5
no_association
IAGP EXP
DNA:polymorphism:promoter:-1131T>C (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-1131T>C, c.56C>G (human)
CTD RGD
PMID:24097064 PMID:15177130 PMID:15306190
RGD:2313322 , RGD:1578412
NCBI chr11:116,789,367...116,792,420
Ensembl chr11:116,789,367...116,792,420
G
APOB
apolipoprotein B
no_association
IAGP IEA
DNA:SNP:CDS:rs1042031 (human)
RGD GAD
PMID:9585673 PMID:28167353 PMID:15118671 PMID:1732399
RGD:1578418 , RGD:329901772 , RGD:1331525 , RGD:1578417
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
G
APOC3
apolipoprotein C3
IAGP EXP IEA
CTD Direct Evidence: marker/mechanism DNA:SNP:promoter:-482C>T, in women without Diabetes Mellitus, Type 2 (MeSH:D003924)
CTD RGD
PMID:24097064 PMID:14709372 PMID:15059615 PMID:15118671
RGD:1578443 , RGD:1626412 , RGD:1331525
NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
G
APOE
apolipoprotein E
susceptibility
IAGP ISO IEA
associated with Diabetes Mellitus, Non-Insulin Dependent;DNA:SNP:promoter:-219G>T (human) DNA:snp, missense mutation:promoter, cds:g.-219G>T, p.C112R (human) DNA:missense mutation:cds:p.C112R (human)
RGD GAD
PMID:15059615 PMID:28808185 PMID:14563588 PMID:15118671 PMID:12860263
RGD:1626412 , RGD:13703132 , RGD:1580039 , RGD:1331525 , RGD:1578449
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
APOM
apolipoprotein M
susceptibility
IAGP
DNA:SNP:promoter:g.-778T>C(rs805296)(human)
RGD
PMID:17674965
RGD:2314241
NCBI chr 6:31,652,404...31,658,210
Ensembl chr 6:31,652,416...31,658,210
G
AR
androgen receptor
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
ARHGAP31
Rho GTPase activating protein 31
susceptibility
IAGP
associated with nicotine dependence;DNA:SNP: (rs10934490) (human)
RGD
PMID:19706030
RGD:329970276
NCBI chr 3:119,294,383...119,420,714
Ensembl chr 3:119,294,383...119,420,714
G
ATP2B1
ATPase plasma membrane Ca2+ transporting 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22751097
NCBI chr12:89,588,049...89,709,366
Ensembl chr12:89,588,049...89,709,366
G
BCHE
butyrylcholinesterase
susceptibility
IAGP
DNA:polymorphism: :p.A539T (human)
RGD
PMID:17852836
RGD:2306777
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
BRINP3
BMP/retinoic acid inducible neural specific 3
IAGP
DNA:SNP: :rs12732361(human), associated with male.
RGD
PMID:27461004
RGD:14398490
NCBI chr 1:190,097,658...190,477,864
Ensembl chr 1:190,097,658...190,478,404
G
BTNL2
butyrophilin like 2
susceptibility
IAGP
associated with Mucocutaneous Lymph Node Syndrome; DNA:SNP: :rs 2395158(human)
RGD
PMID:19882345
RGD:9685030
NCBI chr 6:32,393,339...32,407,181
Ensembl chr 6:32,393,339...32,407,181
G
C1orf167
chromosome 1 open reading frame 167
IAGP
DNA:SNP: :rs56001051(human)
RGD
PMID:31175347
RGD:14696712
NCBI chr 1:11,762,193...11,789,585
Ensembl chr 1:11,761,787...11,789,585
G
CARF
calcium responsive transcription factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 2:202,912,275...202,988,263
Ensembl chr 2:202,912,214...202,988,263
G
CBS
cystathionine beta-synthase
IAGP
CBS variant c.844ins68
RGD
PMID:12855221
RGD:1600626
NCBI chr21:43,053,191...43,076,873
Ensembl chr21:43,053,191...43,076,943
G
CCL2
C-C motif chemokine ligand 2
ISO IAGP EXP IEP
protein:increased expression:myocardium (rat) ClinVar Annotator: match by term: Coronary artery disease, modifier of CTD Direct Evidence: marker/mechanism protein:increased expression:serum (human)
ClinVar CTD RGD
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:16934270 PMID:18940815 PMID:25741868 PMID:16297799 PMID:9537339 More...
RGD:8549513 , RGD:8549577
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL26
C-C motif chemokine ligand 26
susceptibility
IEP
protein:decreased expression:plasma (human)
RGD
PMID:16620281
RGD:11081161
NCBI chr 7:75,769,524...75,791,597
Ensembl chr 7:75,769,533...75,789,896
G
CCR1
C-C motif chemokine receptor 1
IEP
RGD
PMID:12742282
RGD:5508477
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CCR2
C-C motif chemokine receptor 2
IAGP
RGD
PMID:12426226
RGD:1581178
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:heart (rat)
RGD
PMID:17449418
RGD:4890438
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CD14
CD14 molecule
no_association
IAGP
DNA:SNP:promoter
RGD
PMID:18157711
RGD:2314154
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD36
CD36 molecule (CD36 blood group)
IAGP
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD40LG
CD40 ligand
IEP EXP IAGP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism associated with Mucocutaneous Lymph Node Syndrome;DNA:SNP: :rs4810485 (human) protein:increased expression:coronary artery, serum associated with Kidney Failure, Chronic
CTD RGD
PMID:16368305 PMID:17635572 PMID:22645426 PMID:23819214 PMID:16494885
RGD:2314209 , RGD:8547776 , RGD:7248750 , RGD:7248436
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
G
CDH5
cadherin 5
IEP
RGD
PMID:14695457
RGD:1598391
NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784
G
CDKN2B
cyclin dependent kinase inhibitor 2B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23104008 PMID:34961328
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
G
CELA2A
chymotrypsin like elastase 2A
IAGP
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:25741868 PMID:31358993
NCBI chr 1:15,456,732...15,472,091
Ensembl chr 1:15,456,728...15,472,091
G
CELSR2
cadherin EGF LAG seven-pass G-type receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 1:109,249,539...109,275,751
Ensembl chr 1:109,249,539...109,275,751
G
CETP
cholesteryl ester transfer protein
IAGP
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:14559957 PMID:17190939 PMID:20068209 PMID:25741868 PMID:28492532
NCBI chr16:56,961,950...56,983,845
Ensembl chr16:56,961,923...56,983,845
G
CHI3L1
chitinase 3 like 1
IEP
protein:increased secretion:serum (human)
RGD
PMID:17627189
RGD:4892665
NCBI chr 1:203,178,931...203,186,704
Ensembl chr 1:203,178,931...203,186,704
G
CLCN6
chloride voltage-gated channel 6
susceptibility
IAGP
DNA:SNP: :rs3737964(human)
RGD
PMID:26740945
RGD:14696742
NCBI chr 1:11,806,191...11,843,130
Ensembl chr 1:11,806,096...11,848,079
G
CLU
clusterin
IEP
associated with Mucocutaneous Lymph Node Syndrome;protein:decreased expression:plasma
RGD
PMID:20711835
RGD:9068393
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
CRP
C-reactive protein
IEP EXP
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24868163 PMID:19615354
RGD:2313344
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CST3
cystatin C
IEP
protein:increased expression:serum (human)
RGD
PMID:17983622
RGD:2314352
NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
G
CUBN
cubilin
susceptibility
IAGP
DNA:SNP,haplotypes:intron: (rs2291521)G>A (human)
RGD
PMID:33004870
RGD:329901841
NCBI chr10:16,823,966...17,129,811
Ensembl chr10:16,823,966...17,129,811
G
CXCL12
C-X-C motif chemokine ligand 12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
G
CYBA
cytochrome b-245 alpha chain
IAGP IEA
RGD GAD
PMID:14709372 PMID:15118671
RGD:1578443 , RGD:1331525
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
IAGP
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
G
CYP2R1
cytochrome P450 family 2 subfamily R member 1
IAGP
DNA:SNP:CDS:rs10741657 (human)
RGD
PMID:25003556
RGD:401901077
NCBI chr11:14,877,440...14,892,443
Ensembl chr11:14,877,440...14,892,231
G
DAB2IP
DAB2 interacting protein
onset
IAGP
DNA:SNP:CDS:rs7025486 (human)
RGD
PMID:30595311
RGD:401938617
NCBI chr 9:121,567,074...121,785,530
Ensembl chr 9:121,567,057...121,785,530
G
DDAH1
dimethylarginine dimethylaminohydrolase 1
IAGP
DNA:missense mutation:cds:rs997251 (human)
RGD
PMID:30284143
RGD:329961317
NCBI chr 1:85,318,485...85,578,200
Ensembl chr 1:85,318,481...85,578,363
G
DDAH2
DDAH family member 2, ADMA-independent
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17267746
NCBI chr 6:31,727,040...31,730,263
Ensembl chr 6:31,727,038...31,730,617
G
ECE1
endothelin converting enzyme 1
IDA IEP
protein:increased expression:smooth muscle cell,macrophage
RGD
PMID:10973835 PMID:8994440
RGD:1580909 , RGD:7244168
NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572
G
EDN1
endothelin 1
treatment severity
IEP ISO IAGP
protein:increased expression:atherosclerotic lesions (human) associated with Hypertension;DNA:missense mutation:cds:p.L198N (human)
RGD
PMID:7968078 PMID:11927217 PMID:18923236
RGD:4144886 , RGD:8662294 , RGD:8661705
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
ENG
endoglin
severity
IEP
protein:increased expression:plasma (human)
RGD
PMID:21667051
RGD:7248776
NCBI chr 9:127,815,016...127,854,658
Ensembl chr 9:127,815,013...127,854,658
G
EPHX2
epoxide hydrolase 2
IAGP
RGD
PMID:14732757
RGD:1580982
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
EPO
erythropoietin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:25245553
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
susceptibility
IAGP
DNA:SNP: :rs13181(human)
RGD
PMID:27566080
RGD:12880440
NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
G
ESR1
estrogen receptor 1
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9396482 PMID:20559769 PMID:16159931
RGD:1580335
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
ESR2
estrogen receptor 2
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20559769 PMID:16099331
RGD:1581014
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
G
F2
coagulation factor II, thrombin
treatment
IDA
RGD
PMID:14961168
RGD:10449426
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
F7
coagulation factor VII
IEP IAGP
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:plasma (human) DNA:polymorphisms:cds:R353Q (human)
RGD
PMID:10599031 PMID:11334615 PMID:8522401
RGD:2312400 , RGD:2312397 , RGD:2312408
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
G
FABP2
fatty acid binding protein 2
IAGP
DNA:SNP:CDS:2445G>A, amino acid A54T, associated with Diabetes Mellitus, Type 2 (MeSH:D003924) in women
RGD
PMID:15059615
RGD:1626412
NCBI chr 4:119,317,250...119,322,138
Ensembl chr 4:119,317,250...119,322,138
G
FCGR2A
Fc gamma receptor IIa
IAGP
DNA:polymorphism: :p.H131R (human)
RGD
PMID:20973705
RGD:5147917
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
FCGR3A
Fc gamma receptor IIIa
susceptibility
IAGP
DNA:SNP:exon:p.F158V (rs396991)(human)
RGD
PMID:15910853
RGD:5508464
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
G
FES
FES proto-oncogene, tyrosine kinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr15:90,884,504...90,895,776
Ensembl chr15:90,883,695...90,895,776
G
FGB
fibrinogen beta chain
IAGP
RGD
PMID:8565160
RGD:1580382
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
G
FGF2
fibroblast growth factor 2
IEP
associated with Diabetes Mellitus
RGD
PMID:14585103
RGD:2315879
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
IAGP
DNA:SNP: :rs9939609 (human) DNA:SNP:intron:rs9939609 (human)
RGD
PMID:24622111 PMID:28167353
RGD:329812039 , RGD:329901772
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
G
FURIN
furin, paired basic amino acid cleaving enzyme
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr15:90,868,588...90,883,457
Ensembl chr15:90,868,588...90,883,564
G
GCK
glucokinase
susceptibility
IAGP
DNA:SNP:promoter:-30G>A (human)
RGD
PMID:15173029
RGD:2301876
NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170
G
GDF15
growth differentiation factor 15
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20855664
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GFOD1
Gfo/Idh/MocA-like oxidoreductase domain containing 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 6:13,357,830...13,487,600
Ensembl chr 6:13,357,830...13,487,662
G
GGCX
gamma-glutamyl carboxylase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 2:85,544,720...85,561,493
Ensembl chr 2:85,544,720...85,561,532
G
GJA4
gap junction protein alpha 4
IAGP
DNA:SNP:CDS:1019C>T, amino acid P319S, in men both with and without Diabetes Mellitus, Type 2 (MeSH:D003924) DNA:SNP:CDS:C allele of 1019C>T, amino acid P319S in men only (p = 0.0047) in a Swiss population
RGD
PMID:15059615 PMID:16677656
RGD:1626412 , RGD:1626615
NCBI chr 1:34,792,999...34,795,747
Ensembl chr 1:34,792,999...34,795,747
G
GNB3
G protein subunit beta 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16141801
NCBI chr12:6,840,925...6,847,393
Ensembl chr12:6,839,954...6,847,393
G
GP6
glycoprotein VI platelet
treatment
IEP
protein:increased expression:platelet (human)
RGD
PMID:18585516
RGD:401794134
NCBI chr19:55,013,705...55,038,264
Ensembl chr19:55,013,705...55,038,264
G
GPX1
glutathione peroxidase 1
IEP IAGP
cardiovascular complications in type 2 diabetics; protein:reduced_activity:blood DNA:repeat:exon
RGD
PMID:16338763 PMID:12655278
RGD:1600708 , RGD:1600677
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GPX3
glutathione peroxidase 3
IEP
mRNA:increased expression:epicardial fat
RGD
PMID:21679057
RGD:401827169
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
GSR
glutathione-disulfide reductase
IEP
cardiovascular complications in type 2 diabetics; protein:reduced_activity:blood
RGD
PMID:16338763
RGD:1600708
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTM1
glutathione S-transferase mu 1
susceptibility
IAGP
associated with Diabetes Mellitus, Non-Insulin-Dependent DNA:deletion
RGD
PMID:19102712 PMID:16620396
RGD:2306625 , RGD:2306633
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTT1
glutathione S-transferase theta 1
susceptibility
IAGP
associated with Diabetes Mellitus, Non-Insulin-Dependent DNA:deletion
RGD
PMID:19102712 PMID:16620396
RGD:2306625 , RGD:2306633
G
GUCY1A1
guanylate cyclase 1 soluble subunit alpha 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22751097
NCBI chr 4:155,666,848...155,737,059
Ensembl chr 4:155,666,726...155,737,059
G
H19
H19 imprinted maternally expressed transcript
susceptibility
IAGP
DNA:SNPs,haplotype:intron: (rs2735971,rs2839698,rs3024270) (human)
RGD
PMID:32454910
RGD:242905209
NCBI chr11:1,995,176...2,001,466
Ensembl chr11:1,995,166...2,004,552
G
HECTD4
HECT domain E3 ubiquitin protein ligase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22751097
NCBI chr12:112,160,195...112,382,431
Ensembl chr12:112,160,188...112,382,439
G
HFE
homeostatic iron regulator
no_association
IAGP
RGD
PMID:12746412
RGD:1582673
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,281...26,098,343
G
HGF
hepatocyte growth factor
IEP
RGD
PMID:11669408
RGD:8548610
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
HHIPL1
HHIP like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr14:99,604,538...99,680,569
Ensembl chr14:99,645,129...99,680,569
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
IMP
RGD
PMID:12742282
RGD:5508477
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMOX1
heme oxygenase 1
no_association susceptibility
IAGP EXP
DNA:repeat:promoter CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12136229 PMID:14691581 PMID:12377749 PMID:12136229
RGD:1580470 , RGD:1580454 , RGD:1598401
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNF1A
HNF1 homeobox A
susceptibility
IAGP
DNA:SNP:intron 1: (rs7310409) G>A (human) DNA:SNP,haplotypes:intron: (rs55783344) C>T(human) DNA:SNPs,haplotypes:multiple
RGD
PMID:25202455 PMID:33004870 PMID:28035729
RGD:329901832 , RGD:329901841 , RGD:329901837
NCBI chr12:120,978,543...121,002,512
Ensembl chr12:120,978,543...121,002,512
G
HP
haptoglobin
IEP
protein:increased expression:serum
RGD
PMID:884791
RGD:1626363
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
HS3ST1
heparan sulfate-glucosamine 3-sulfotransferase 1
IAGP
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:15266341 PMID:15965027 PMID:16024819 PMID:16410828 PMID:17179217 PMID:17558387 PMID:17568005 PMID:19122651 PMID:19303047 PMID:19858363 PMID:21152010 PMID:22090374 PMID:28126521 More...
NCBI chr 4:11,393,150...11,434,327
Ensembl chr 4:11,393,150...11,429,564
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
sexual_dimorphism
IEP
associated with obesity;mRNA,protein:increased expression:multiple (human)
RGD
PMID:23009206
RGD:329901914
NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949
G
HSPD1
heat shock protein family D (Hsp60) member 1
severity
IDA
RGD
PMID:11222468
RGD:1624218
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
ICA1L
islet cell autoantigen 1 like
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 2:202,773,176...202,871,766
Ensembl chr 2:202,773,150...202,871,766
G
IL10
interleukin 10
no_association susceptibility
IEP IAGP
DNA:SNPs:promoter:-592C>A (rs1800872), -819C>T (rs1800871) (human) DNA:SNP:promoter:-1082A>G (rs1800896) (human)
RGD
PMID:16460885 PMID:29525679 PMID:29525679
RGD:1598621 , RGD:14975129 , RGD:14975129
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL15
interleukin 15
IEP
associated with Hypertension;protein:increased expression:serum
RGD
PMID:16109314
RGD:1626610
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
G
IL1B
interleukin 1 beta
IEP
mRNA:increased expression:peripheral blood (human)
RGD
PMID:22780915
RGD:7175093
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
severity
IAGP
DNA:polymorphisms: :-27307T>A, -27614C>A (human)
RGD
PMID:20602249
RGD:5144241
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL6
interleukin 6
IEP
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased expression:extracellular space (human)
RGD
PMID:19368923
RGD:2307251
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IRAK1
interleukin 1 receptor associated kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20524934
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
G
IRS1
insulin receptor substrate 1
IAGP EXP
DNA:polymorphism:exon:G972R CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10591678 PMID:10591678
RGD:1624974
NCBI chr 2:226,731,312...226,799,820
Ensembl chr 2:226,731,312...226,799,820
G
ITGA2
integrin subunit alpha 2
no_association
IAGP
RGD
PMID:15227729
RGD:1582294
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
JCAD
junctional cadherin 5 associated
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378988
NCBI chr10:30,012,803...30,115,494
Ensembl chr10:30,012,803...30,115,494
G
KALRN
kalirin RhoGEF kinase
susceptibility onset severity
IAGP
DNA:SNP:intron: (rs9289231) T>G (human) associated with nicotine dependence; DNA:SNPs:multiple associated with type 2 diabetes mellitus;DNA:SNP:intron: (rs9289231) T>G (human) DNA:SNP:intron: (rs9289231) (human)
RGD
PMID:30483314 PMID:19706030 PMID:27218147 PMID:25316661
RGD:329955537 , RGD:329970276 , RGD:329956419 , RGD:11076452
NCBI chr 3:124,033,369...124,726,325
Ensembl chr 3:124,033,369...124,726,325
G
KCNE2
potassium voltage-gated channel subfamily E regulatory subunit 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr21:34,364,006...34,371,381
Ensembl chr21:34,364,006...34,371,381
G
KCNJ8
potassium inwardly rectifying channel subfamily J member 8
ISS
OMIM:300464 | OMIM:607339 | OMIM:608316 | OMIM:608318 | OMIM:608320 | OMIM:608901 | OMIM:610938 | OMIM:610947 | OMIM:611139 | OMIM:612030 | OMIM:614293 | OMIM:614466
MouseDO
NCBI chr12:21,764,955...21,774,706
Ensembl chr12:21,764,955...21,775,600
G
KIF6
kinesin family member 6
sexual_dimorphism no_association treatment
IAGP
DNA:SNP: :rs20455 (human) associated with type 2 diabetes mellitus;DNA:SNP: :p.W719R (rs20455) (human)
RGD
PMID:18222354 PMID:25629058 PMID:21458191 PMID:26443250 PMID:26997531 PMID:19371834 More...
RGD:243048446 , RGD:243048454 , RGD:243048451 , RGD:11527801 , RGD:243048449 , RGD:243048447
NCBI chr 6:39,329,990...39,725,408
Ensembl chr 6:39,329,990...39,725,408
G
KL
klotho
IAGP EXP
DNA:SNP:promoter: -G395>A (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12669274 PMID:16579981 PMID:16979405
RGD:1581723 , RGD:1581721
NCBI chr13:33,016,243...33,066,143
Ensembl chr13:33,016,423...33,066,143
G
LDLR
low density lipoprotein receptor
no_association
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21378990 PMID:27135400 PMID:16459141
RGD:1581823
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LEPR
leptin receptor
susceptibility
IAGP
DNA:missense mutation:CDS:p.Q223R (human)
RGD
PMID:27257426
RGD:21079462
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
LIPA
lipase A, lysosomal acid type
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378988 PMID:34961328 PMID:35590109
NCBI chr10:89,213,572...89,251,775
Ensembl chr10:89,213,569...89,414,557
G
LIPC
lipase C, hepatic type
susceptibility no_association
IAGP IEA
250G/A DNA:SNP,haplotypes: (rs17269397)A>G (human) associated with Diabetes Mellitus, Insulin-Dependent; DNA:transition:promoter:-480C>T (human) C514T
RGD GAD
PMID:15099346 PMID:33004870 PMID:11916946 PMID:15118671 PMID:12689525
RGD:1600663 , RGD:329901841 , RGD:2308839 , RGD:1331525 , RGD:1600664
NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
G
LIPG
lipase G, endothelial type
IDA
RGD
PMID:16354105
RGD:1580865
NCBI chr18:49,561,479...49,599,185
Ensembl chr18:49,560,699...49,599,185
G
LMOD1
leiomodin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28530674
NCBI chr 1:201,896,456...201,946,548
Ensembl chr 1:201,896,456...201,946,548
G
LOC126862536
BRD4-independent group 4 enhancer GRCh37_chr17:32578883-32580082
IAGP
ClinVar Annotator: match by term: Coronary artery disease, modifier of
ClinVar
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:18940815 PMID:25741868 More...
NCBI chr17:34,251,864...34,253,063
G
LOX
lysyl oxidase
ISO
RGD
PMID:12393934
RGD:1581886
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LPA
lipoprotein(a)
IEP IAGP EXP
protein:increased expression:plasma:increased levels of β(2)-GPI-Lp(a) complex, Lp(a) and/or ox-Lp(a) ClinVar Annotator: match by term: LIPOPROTEIN(a) POLYMORPHISM CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:20435227 PMID:21378990 PMID:22056596
RGD:5509899
NCBI chr 6:160,531,482...160,664,275
Ensembl chr 6:160,531,482...160,664,275
G
LPL
lipoprotein lipase
IAGP
RGD
PMID:8641022
RGD:1580537
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
LRP6
LDL receptor related protein 6
IAGP
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:28492532
NCBI chr12:12,116,025...12,267,044
Ensembl chr12:12,116,025...12,267,044
G
LRP8
LDL receptor related protein 8
no_association onset
IAGP
DNA:missense mutation:cds:p.R952Q (human)
RGD
PMID:18592168 PMID:17847002
RGD:2306125 , RGD:2306124
NCBI chr 1:53,242,364...53,328,070
Ensembl chr 1:53,242,364...53,328,469
G
LTA
lymphotoxin alpha
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15266304 PMID:15973460
RGD:1580414
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
G
LUM
lumican
IDA
RGD
PMID:11890723
RGD:1582121
NCBI chr12:91,102,629...91,111,494
Ensembl chr12:91,102,629...91,111,494
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
IEP
associated with hypothyroidism;mRNA:decreased expression:venous blood (human)
RGD
PMID:32495070
RGD:155791451
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
G
MAT2A
methionine adenosyltransferase 2A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
G
MEF2A
myocyte enhancer factor 2A
TAS
RGD
PMID:15811259
RGD:1580548
NCBI chr15:99,565,417...99,716,488
Ensembl chr15:99,565,417...99,716,488
G
MIA3
MIA SH3 domain ER export factor 3
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Coronary artery disease
CTD ClinVar
PMID:21378990 PMID:25741868 PMID:34961328
NCBI chr 1:222,618,097...222,668,007
Ensembl chr 1:222,618,097...222,668,007
G
MIR1-2
microRNA 1-2
disease_progression
IEP
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr18:21,829,004...21,829,088
Ensembl chr18:21,829,004...21,829,088
G
MIR126
microRNA 126
disease_progression severity
IEP
miRNA:increased expression:blood plasma (human) associated with Stable Angina,
RGD
PMID:25728840 PMID:27497911
RGD:11056497 , RGD:401850779
NCBI chr 9:136,670,602...136,670,686
Ensembl chr 9:136,670,602...136,670,686
G
MIR133A1
microRNA 133a-1
IEP
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr18:21,825,698...21,825,785
Ensembl chr18:21,825,698...21,825,785
G
MIR145
microRNA 145
disease_progression
IEP
miRNA:decreased expression:artery wall (human)
RGD
PMID:25938589
RGD:11054026
NCBI chr 5:149,430,646...149,430,733
Ensembl chr 5:149,430,646...149,430,733
G
MIR146A
microRNA 146a
susceptibility
EXP IAGP IEP
CTD Direct Evidence: marker/mechanism DNA:SNP: (rs2910164) (human) miRNA:increased expression:peripheral blood mononuclear cell, plasma
CTD RGD
PMID:20524934 PMID:26909569 PMID:31866771
RGD:329337364 , RGD:21081515
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
G
MIR146B
microRNA 146b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20524934
NCBI chr10:102,436,512...102,436,584
Ensembl chr10:102,436,512...102,436,584
G
MIR155
microRNA 155
IEP
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR195
microRNA 195
IEP
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr17:7,017,615...7,017,701
Ensembl chr17:7,017,615...7,017,701
G
MIR208A
microRNA 208a
IEP
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr14:23,388,596...23,388,666
Ensembl chr14:23,388,596...23,388,666
G
MIR21
microRNA 21
IEP
miRNA:increased expression:peripheral blood mononuclear cell, plasma miRNA:increased expression:blood plasma (human)
RGD
PMID:31866771 PMID:25728840
RGD:21081515 , RGD:11056497
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
G
MIR214
microRNA 214
IEP
miRNA:increased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr 1:172,138,798...172,138,907
Ensembl chr 1:172,138,798...172,138,907
G
MIR223
microRNA 223
treatment
IEP
RGD
PMID:25350775
RGD:11076984
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
MIR30A
microRNA 30a
disease_progression
IEP
miRNA:increased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr 6:71,403,551...71,403,621
Ensembl chr 6:71,403,551...71,403,621
G
MIR30E
microRNA 30e
IEP
miRNA:increased expression:plasma, extracellular exosome (human)
RGD
PMID:30816508
RGD:401827150
NCBI chr 1:40,754,355...40,754,446
Ensembl chr 1:40,754,355...40,754,446
G
MIR320A
microRNA 320a
disease_progression
IEP
miRNA:increased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043
G
MIR423
microRNA 423
disease_progression
IAGP IEP
DNA:SNP: :rs6505162 (human) miRNA:decreased expression:serum
RGD
PMID:30289085 PMID:32404537
RGD:158014893 , RGD:158014898
NCBI chr17:30,117,079...30,117,172
Ensembl chr17:30,117,079...30,117,172
G
MLXIPL
MLX interacting protein like
susceptibility
IAGP
DNA:SNPs,haplotypes: (rs3812316) (human) DNA:SNP:cds: G771C, Q241H (rs381231) DNA:SNP:cds: C771G, H241Q
RGD
PMID:21726544 PMID:19571538 PMID:25179879
RGD:401794579 , RGD:401794582 , RGD:401794581
NCBI chr 7:73,593,202...73,647,907
Ensembl chr 7:73,593,194...73,624,543
G
MMP1
matrix metallopeptidase 1
severity
IDA IAGP
DNA:insertion, haplotype:promoter:g.-1607insG rs799750 (human)
RGD
PMID:15619398 PMID:17893005
RGD:1582527 , RGD:7207049
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP12
matrix metallopeptidase 12
susceptibility
IAGP
RGD
PMID:10807873
RGD:1582366
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
G
MMP3
matrix metallopeptidase 3
IAGP EXP
DNA:insertion, haplotype:promoter:g.-1613insA rs3025058 (human) CTD Direct Evidence: marker/mechanism associated with Mucocutaneous Lymph Node Syndrome
CTD RGD
PMID:8662692 PMID:17893005 PMID:16100452
RGD:7207049 , RGD:8693322
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MMP9
matrix metallopeptidase 9
susceptibility treatment
IAGP ISO
RGD
PMID:15191941 PMID:26261622
RGD:1582644 , RGD:11344965
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MRAS
muscle RAS oncogene homolog
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:35590109
NCBI chr 3:138,347,648...138,405,535
Ensembl chr 3:138,347,648...138,405,534
G
MRPS6
mitochondrial ribosomal protein S6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:34961328
NCBI chr21:34,073,578...34,143,030
Ensembl chr21:34,073,224...34,143,034
G
MTHFR
methylenetetrahydrofolate reductase
no_association susceptibility
IAGP
DNA:transition:cds:g.677C>T (human) DNA:SNPs: (rs1801133, rs4846049) (Human)
RGD
PMID:15648053 PMID:24315498 PMID:12387655
RGD:1580579 , RGD:401850782 , RGD:6893453
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
MYLIP
myosin regulatory light chain interacting protein
IAGP
ClinVar Annotator: match by term: Coronary atherosclerosis
ClinVar
NCBI chr 6:16,129,086...16,163,887
Ensembl chr 6:16,129,086...16,148,248
G
MYLK
myosin light chain kinase
susceptibility
IAGP
associated with nicotine dependence; DNA:SNP: (rs16834817)
RGD
PMID:19706030
RGD:329970276
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
G
NAMPT
nicotinamide phosphoribosyltransferase
IEP
RGD
PMID:17283255
RGD:1642340
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
G
NAT2
N-acetyltransferase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21572414
NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
G
NBEAL1
neurobeachin like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 2:203,014,608...203,225,194
Ensembl chr 2:203,014,608...203,226,378
G
NGF
nerve growth factor
IEP
RGD
PMID:11935372
RGD:1580935
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NGFR
nerve growth factor receptor
IEP
RGD
PMID:11935372
RGD:1580935
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NNMT
nicotinamide N-methyltransferase
severity
IEP
protein:increased expression:blood serum (human)
RGD
PMID:28174167
RGD:401793727
NCBI chr11:114,257,806...114,313,536
Ensembl chr11:114,257,787...114,313,536
G
NOD2
nucleotide binding oligomerization domain containing 2
IAGP
DNA:polymorphisms: :p.G908R, 3020_3021insC (human)
RGD
PMID:21565239
RGD:5508725
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
NOS2
nitric oxide synthase 2
IEP
associated with Mucocutaneous Lymph Node Syndrome; protein:increased expression:neutrophil, monocyte
RGD
PMID:14764920
RGD:1580941
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
susceptibility
IAGP EXP
DNA:duplication:intron:IVS4?-?+27 (human) CTD Direct Evidence: marker/mechanism DNA:snp:promoter:g.-786T>C (human) DNA:snp:cds:c.894G>T (human)
CTD RGD
PMID:10510054 PMID:14989558 PMID:17267746 PMID:19696404 PMID:8564837 PMID:19761682 PMID:16284093 More...
RGD:7421529 , RGD:7771578 , RGD:7771567
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NPPA
natriuretic peptide A
IAGP
DNA:snp:cds:c.2238T>C (human) associated with Diabetes Mellitus, Type 2;DNA:SNP:exon: 2238T>C,rs5065 (human)
RGD
PMID:12514664 PMID:22170009
RGD:1579982 , RGD:7247716
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
G
NPPB
natriuretic peptide B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18022110
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
G
NR1H3
nuclear receptor subfamily 1 group H member 3
IEP
associated with type 2 diabetes mellitus;mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:28871240
RGD:401850555
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
NR3C1
nuclear receptor subfamily 3 group C member 1
IAGP
DNA:missense mutation:cds:p.N363S (human)
RGD
PMID:12623935
RGD:1580790
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
OGG1
8-oxoguanine DNA glycosylase
susceptibility
IAGP
DNA:SNP,haplotype: :p.S326C (rs1052133) (human)
RGD
PMID:23368530
RGD:401827273
NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219
G
OLR1
oxidized low density lipoprotein receptor 1
severity
IAGP
DNA:missense mutation:cds:p.K167N (human) DNA:snp:3' utr:T>C (human)
RGD
PMID:15562935 PMID:12810610
RGD:1580994 , RGD:1580995
NCBI chr12:10,158,301...10,176,266
Ensembl chr12:10,158,301...10,172,138
G
PAPPA
pappalysin 1
severity
IEP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11586954 PMID:16055491
RGD:1642327
NCBI chr 9:116,153,791...116,402,321
Ensembl chr 9:116,153,791...116,402,321
G
PARL
presenilin associated rhomboid like
susceptibility
IAGP
DNA:missense mutation:cds:p.L262V (human)
RGD
PMID:18758826
RGD:12902623
NCBI chr 3:183,826,489...183,884,880
Ensembl chr 3:183,829,271...183,884,933
G
PCSK9
proprotein convertase subtilisin/kexin type 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:27135400
NCBI chr 1:55,039,548...55,064,852
Ensembl chr 1:55,039,447...55,064,852
G
PDGFD
platelet derived growth factor D
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378988 PMID:34961328
NCBI chr11:103,907,189...104,164,147
Ensembl chr11:103,907,189...104,164,379
G
PECAM1
platelet and endothelial cell adhesion molecule 1
no_association
IAGP EXP
DNA:polymorphism:5' utr:g.53G>A (human) CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.L125V (human) DNA:missense mutations:cds:p.N536S, p.G670R (human)
CTD RGD
PMID:28530674 PMID:12732396 PMID:10780329 PMID:11795274
RGD:1581010 , RGD:6771225 , RGD:2311656
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PF4V1
platelet factor 4 variant 1
IEP
protein:increased expression:plasma
RGD
PMID:26283469
RGD:401794584
NCBI chr 4:73,853,296...73,854,483
Ensembl chr 4:73,853,296...73,854,483
G
PHACTR1
phosphatase and actin regulator 1
susceptibility sexual_dimorphism
EXP IDA IAGP
CTD Direct Evidence: marker/mechanism DNA:hypermethylation, hypomethylation:promoter, exon: (human) DNA:SNP:exon: (rs4714955) (human) DNA:SNPs:intron: (rs9381439, rs9349379) (human) associated with familial hypercholesterolemia;DNA:SNP:intron: (rs12526453) (human) DNA:SNP:intron:g.12903957A>G (rs9349379) (human) DNA:SNP:intron:g.12903725A>G (rs9349379) (human)
CTD RGD
PMID:21378990 PMID:22751097 PMID:26098115 PMID:34961328 PMID:31499127 PMID:27066539 PMID:27893421 PMID:29784573 PMID:27517945 PMID:30777881 More...
RGD:401901251 , RGD:401901243 , RGD:401900688 , RGD:401900687 , RGD:401900135 , RGD:401851919
NCBI chr 6:12,716,767...13,287,837
Ensembl chr 6:12,716,312...13,290,446
G
PIK3C2G
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma
IAGP
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr12:18,242,961...18,726,817
Ensembl chr12:18,242,961...18,648,416
G
PLA2G7
phospholipase A2 group VII
disease_progression susceptibility
IEP IAGP
DNA:polymorphism: :p.A379V (human)
RGD
PMID:17070179 PMID:15115767
RGD:6482777 , RGD:6482781
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
PLPP3
phospholipid phosphatase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 1:56,494,761...56,579,563
Ensembl chr 1:56,494,761...56,645,301
G
PNPLA3
patatin like phospholipase domain containing 3
IAGP
associated with type 2 diabetes mellitus;DNA:SNP: :rs738409 (p.I148M) (human)
RGD
PMID:31377187
RGD:14981594
NCBI chr22:43,923,805...43,947,582
Ensembl chr22:43,923,792...43,964,488
G
PON1
paraoxonase 1
susceptibility
IAGP EXP IEP
DNA:missense mutation:cds:p.Q192R (human) ClinVar Annotator: match by term: Coronary artery spasm 2, susceptibility to CTD Direct Evidence: marker/mechanism|therapeutic protein:increased activity:serum (human)
ClinVar CTD RGD
PMID:7916578 PMID:8098250 PMID:8675673 PMID:8770857 PMID:9215303 PMID:9385372 PMID:9443884 PMID:11238489 PMID:11810302 PMID:11888590 PMID:12082503 PMID:15241482 PMID:21170047 PMID:21629682 PMID:25741868 PMID:10729395 PMID:15785307 PMID:11917194 More...
RGD:1580196 , RGD:8547681 , RGD:1580203
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
PON2
paraoxonase 2
severity
IAGP
DNA:missense mutation:cds:p.C311S (human)
RGD
PMID:12454802
RGD:1580217
NCBI chr 7:95,404,862...95,435,028
Ensembl chr 7:95,404,862...95,435,329
G
PPARA
peroxisome proliferator activated receptor alpha
susceptibility
IAGP
DNA:snp:intron: (human)
RGD
PMID:16043164
RGD:1580228
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARG
peroxisome proliferator activated receptor gamma
IEP
protein:decreased expression:carotid artery, macrophage, smooth muscle cell (human)
RGD
PMID:21709632
RGD:8552814
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPP4C
protein phosphatase 4 catalytic subunit
HEP
mRNA:decreased expression:blood (human)
RGD
PMID:30015926
RGD:401901084
NCBI chr16:30,075,994...30,085,376
Ensembl chr16:30,075,978...30,085,376
G
PRDM16
PR/SET domain 16
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35590109
NCBI chr 1:3,069,203...3,438,621
Ensembl chr 1:3,069,168...3,438,621
G
PRKAG2
protein kinase AMP-activated non-catalytic subunit gamma 2
IAGP
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 7:151,556,127...151,877,115
Ensembl chr 7:151,556,124...151,877,214
G
PROCR
protein C receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28530674
NCBI chr20:35,171,096...35,216,259
Ensembl chr20:35,172,072...35,216,240
G
PSRC1
proline and serine rich coiled-coil 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 1:109,279,556...109,283,145
Ensembl chr 1:109,279,556...109,283,186
G
PTGS2
prostaglandin-endoperoxide synthase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:14642682
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTH
parathyroid hormone
IEP
protein:increased expression:serum (human)
RGD
PMID:23460043
RGD:7242420
NCBI chr11:13,492,054...13,496,181
Ensembl chr11:13,492,054...13,496,181
G
PTPN1
protein tyrosine phosphatase non-receptor type 1
IAGP
DNA:SNP:exon 8:g.981C>T (human)
RGD
PMID:21676396
RGD:401965429
NCBI chr20:50,510,383...50,585,241
Ensembl chr20:50,510,321...50,585,241
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
IAGP
DNA: snp: cds: rs2476601
RGD
PMID:21846984
RGD:6484553
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
G
PTPRD
protein tyrosine phosphatase receptor type D
IAGP
DNA:SNP:intron: (rs10115782) (human)
RGD
PMID:22216278
RGD:401976461
NCBI chr 9:8,314,246...10,613,002
Ensembl chr 9:8,314,246...10,613,002
G
RBP4
retinol binding protein 4
sexual_dimorphism susceptibility severity disease_progression
IEP IAGP
protein:increased expression:blood plasma (human) DNA:SNP:intron: (rs7094671) (human) associated with hypothyroidism;protein:increased expression:blood serum (human) protein:increased expression:epicardial fat (human)
RGD
PMID:25437889 PMID:25479076 PMID:31278889 PMID:18854400 PMID:21645024
RGD:329845573 , RGD:329845882 , RGD:329845849 , RGD:329845843 , RGD:329845584
NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744
G
RYR2
ryanodine receptor 2
IAGP
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr 1:237,042,184...237,833,988
Ensembl chr 1:237,042,184...237,833,988
G
SARS1
seryl-tRNA synthetase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 1:109,213,893...109,238,182
Ensembl chr 1:109,213,918...109,238,182
G
SELE
selectin E
susceptibility
IAGP
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:mutation: :p.S128R (human) ClinVar Annotator: match by term: Coronary artery disease
ClinVar RGD
PMID:25741868 PMID:17578587
RGD:2313596
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
G
SELP
selectin P
IAGP
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
SERPINA1
serpin family A member 1
IEP
protein:increased expression:serum
RGD
PMID:7832094
RGD:1643149
NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
G
SERPINE1
serpin family E member 1
susceptibility
IAGP
DNA:insertion:promoter: (human)
RGD
PMID:9484978
RGD:1580190
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPINF2
serpin family F member 2
IEP
RGD
PMID:9184412
RGD:1625532
NCBI chr17:1,742,871...1,755,265
Ensembl chr17:1,742,836...1,755,265
G
SH2B3
SH2B adaptor protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr12:111,404,730...111,451,623
Ensembl chr12:111,405,923...111,451,623
G
SLC2A4
solute carrier family 2 member 4
IEP
mRNA:decreased expression:epicardial fat, subcutaneous adipose tissue (human)
RGD
PMID:21645024
RGD:329845584
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
G
SLC5A3
solute carrier family 5 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr21:34,073,578...34,106,260
Ensembl chr21:34,073,578...34,106,260
G
SMAD3
SMAD family member 3
IAGP
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:25741868
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
G
SOAT2
sterol O-acyltransferase 2
susceptibility
IAGP
DNA:polymorphisms: :p.E41G, p.T734I, IVS4-57_-58ins48bp (human)
RGD
PMID:16195894
RGD:1601112
NCBI chr12:53,103,486...53,124,535
Ensembl chr12:53,103,486...53,124,535
G
SOD1
superoxide dismutase 1
IEP
associated with Diabetes Mellitus, Non-Insulin-Dependent
RGD
PMID:16338763
RGD:1600708
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD3
superoxide dismutase 3
IDA
RGD
PMID:10811593
RGD:1580853
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
G
SORT1
sortilin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:34961328
NCBI chr 1:109,309,575...109,397,918
Ensembl chr 1:109,309,568...109,397,918
G
SPP1
secreted phosphoprotein 1
IEP
In type 2 diabetic patients
RGD
PMID:21034455
RGD:6903271
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SREBF1
sterol regulatory element binding transcription factor 1
susceptibility disease_progression severity
IAGP IEP
DNA:SNP, haplotype:: -36delG (human) associated with type 2 diabetes mellitus; mRNA:increased expression:epicardial fat (human) mRNA:decreased expression:blood serum (human)
RGD
PMID:12752570 PMID:28367087 PMID:31610782
RGD:401827912 , RGD:401842368 , RGD:401842364
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
SREBF2
sterol regulatory element binding transcription factor 2
disease_progression
IEP
associated with type 2 diabetes mellitus;mRNA:increased expression:epicardial fat (human)
RGD
PMID:28367087
RGD:401842368
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
G
TAP1
transporter 1, ATP binding cassette subfamily B member
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
G
TBC1D7
TBC1 domain family member 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 6:13,304,951...13,328,537
Ensembl chr 6:13,266,542...13,328,583
G
TBX2
T-box transcription factor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35590109
NCBI chr17:61,399,843...61,409,466
Ensembl chr17:61,399,843...61,409,466
G
TCF21
transcription factor 21
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:SNP: (rs12190287) (human)
CTD RGD
PMID:21378990 PMID:22751097 PMID:26909569
RGD:329337364
NCBI chr 6:133,889,113...133,895,537
Ensembl chr 6:133,889,113...133,895,553
G
TEK
TEK receptor tyrosine kinase
IEP
protein:increased expression:plasma
RGD
PMID:12814387
RGD:1601489
NCBI chr 9:27,109,141...27,230,178
Ensembl chr 9:27,109,141...27,230,174
G
TERT
telomerase reverse transcriptase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16890917
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
TGFB1
transforming growth factor beta 1
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
THBD
thrombomodulin
severity
IEP
RGD
PMID:17012137
RGD:1601638
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
TLL1
tolloid like 1
severity
IAGP
associated with type 2 diabetes:DNA:SNP:CDS:rs1503298 (human)
RGD
PMID:21911782
RGD:155883159
NCBI chr 4:165,873,237...166,104,457
Ensembl chr 4:165,873,237...166,104,457
G
TLR4
toll like receptor 4
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20524934 PMID:15632890
RGD:1580736
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
IAGP
DNA:SNP:promoter:-863C>A, in men without Diabetes Mellitus, Type 2 (MeSH:D003924)
RGD
PMID:15059615
RGD:1626412
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF11B
TNF receptor superfamily member 11b
IEP
protein:increased expression:serum
RGD
PMID:15926884
RGD:1620893
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
G
TNFRSF1A
TNF receptor superfamily member 1A
severity
IEP
RGD
PMID:19845893
RGD:5131425
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNNI3
troponin I3, cardiac type
IEP
RGD
PMID:12221049
RGD:1580780
NCBI chr19:55,151,767...55,157,732
Ensembl chr19:55,151,767...55,157,773
G
TP53
tumor protein p53
IAGP
DNA:misssense mutation: :p.R72P (rs1042522) (human)
RGD
PMID:29482350
RGD:14995930
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TRAF6
TNF receptor associated factor 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20524934
NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
G
TRIB1
tribbles pseudokinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097064
NCBI chr 8:125,430,358...125,438,403
Ensembl chr 8:125,430,358...125,438,403
G
TTN
titin
IEP
RGD
PMID:12221049
RGD:1580780
NCBI chr 2:178,525,989...178,807,423
Ensembl chr 2:178,525,989...178,830,802
G
TWIST1
twist family bHLH transcription factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 7:19,113,047...19,117,636
Ensembl chr 7:19,020,991...19,117,636
G
VAMP5
vesicle associated membrane protein 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 2:85,584,431...85,593,406
Ensembl chr 2:85,584,431...85,593,406
G
VAMP8
vesicle associated membrane protein 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 2:85,577,586...85,582,031
Ensembl chr 2:85,561,562...85,582,031
G
VDR
vitamin D receptor
severity
IAGP
DNA:SNP (human)
RGD
PMID:9761785
RGD:4889864
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
VEGFA
vascular endothelial growth factor A
IEP EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:14668888 PMID:15937083 PMID:15754021
RGD:1580569
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VIM
vimentin
IEP
protein:increased expression:monocyte
RGD
PMID:21938407
RGD:6480617
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
VTN
vitronectin
IEP
RGD
PMID:15678274
RGD:1580816
NCBI chr17:28,367,284...28,370,307
Ensembl chr17:28,367,284...28,373,091
G
WDR12
WD repeat domain 12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 2:202,874,261...202,911,673
Ensembl chr 2:202,874,261...203,014,798
G
WRN
WRN RecQ like helicase
IAGP
RGD
PMID:11186893
RGD:1580824
NCBI chr 8:31,033,810...31,176,138
Ensembl chr 8:31,033,788...31,176,138
G
XRCC1
X-ray repair cross complementing 1
onset
IAGP
DNA:polymorphism:: (rs1799782) (human)
RGD
PMID:24315498
RGD:401850782
NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473
G
XRCC3
X-ray repair cross complementing 3
susceptibility
IAGP
DNA:SNP,haplotypes:exon 7: p.T241M (rs861539) (Human)
RGD
PMID:23368530
RGD:401827273
NCBI chr14:103,697,617...103,715,451
Ensembl chr14:103,697,609...103,715,504
G
ZC3HC1
zinc finger C3HC-type containing 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 7:130,018,286...130,051,451
Ensembl chr 7:130,018,287...130,051,451
G
ZFYVE21
zinc finger FYVE-type containing 21
IAGP
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr14:103,715,810...103,733,664
Ensembl chr14:103,715,730...103,733,668
G
ZHX3
zinc fingers and homeoboxes 3
IAGP
ClinVar Annotator: match by term: Coronary atherosclerosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chr20:41,178,455...41,317,731
Ensembl chr20:41,178,448...41,317,731
G
MEF2A
myocyte enhancer factor 2A
IAGP EXP
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant, 1 CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Coronary artery disease/myocardial infarction
ClinVar CTD OMIM
PMID:14645853 PMID:15496429 PMID:15841183
NCBI chr15:99,565,417...99,716,488
Ensembl chr15:99,565,417...99,716,488
G
LRP6
LDL receptor related protein 6
IAGP EXP
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant 2 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:17332414 PMID:23703864 PMID:25741868 PMID:28492532
NCBI chr12:12,116,025...12,267,044
Ensembl chr12:12,116,025...12,267,044
G
CCL2
C-C motif chemokine ligand 2
IAGP
ClinVar Annotator: match by term: Coronary artery disease, development of, in HIV
ClinVar
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:18940815 PMID:25741868 More...
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
LOC126862536
BRD4-independent group 4 enhancer GRCh37_chr17:32578883-32580082
IAGP
ClinVar Annotator: match by term: Coronary artery disease, development of, in HIV
ClinVar
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:18940815 PMID:25741868 More...
NCBI chr17:34,251,864...34,253,063
G
ARHGAP9
Rho GTPase activating protein 9
IAGP EXP
ClinVar Annotator: match by term: Coronary artery spasm 3, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:19911011
NCBI chr12:57,472,269...57,488,824
Ensembl chr12:57,472,264...57,488,814
G
LOC110973015
NOS3 5' regulatory region
IAGP
ClinVar Annotator: match by term: Coronary artery spasm 1, susceptibility to
ClinVar
PMID:10359729
NCBI chr 7:150,988,222...150,994,377
G
NOS3
nitric oxide synthase 3
IAGP EXP
ClinVar Annotator: match by term: Coronary artery spasm 1, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:9737779 PMID:9894802 PMID:10359729 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 More...
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
PON1
paraoxonase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11810302
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
ALDH1A2
aldehyde dehydrogenase 1 family member A2
disease_progression
IAGP
RGD
PMID:26315408
RGD:14367880
NCBI chr15:57,953,429...58,065,711
Ensembl chr15:57,953,424...58,497,866
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
IEP
mRNA:increased expression:heart:
RGD
PMID:21439970
RGD:7257651
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
ACE
angiotensin I converting enzyme
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9236417
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:12138120
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
AHSP
alpha hemoglobin stabilizing protein
HEP
mRNA:decreased expression:blood (human)
RGD
PMID:35144391
RGD:329961301
NCBI chr16:31,527,900...31,528,803
Ensembl chr16:31,527,900...31,528,803
G
BCHE
butyrylcholinesterase
susceptibility
IAGP
DNA:polymorphism: :p.A539T (human)
RGD
PMID:17275003
RGD:2306778
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
CDH13
cadherin 13
ISO
protein:increased expression:artery, smooth muscle cell
RGD
PMID:12376824
RGD:2293553
NCBI chr16:82,626,969...83,800,640
Ensembl chr16:82,626,965...83,800,640
G
CXCL10
C-X-C motif chemokine ligand 10
IEP
protein:increased expression:plasma
RGD
PMID:14578618
RGD:1598500
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCR3
C-X-C motif chemokine receptor 3
IEP
RGD
PMID:14578618
RGD:1598500
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
F2R
coagulation factor II thrombin receptor
ISO
RGD
PMID:14529396
RGD:1581036
NCBI chr 5:76,716,126...76,735,770
Ensembl chr 5:76,716,126...76,735,770
G
HMOX1
heme oxygenase 1
susceptibility
IAGP TAS
RGD
PMID:16020495 PMID:14529548
RGD:1598402 , RGD:1580472
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
ITGB2
integrin subunit beta 2
IAGP
RGD
PMID:11703955
RGD:1581185
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
G
LOX
lysyl oxidase
ISO
RGD
PMID:15218472
RGD:1581881
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
MAPK1
mitogen-activated protein kinase 1
ISO
RGD
PMID:15583728
RGD:1582284
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MBL2
mannose binding lectin 2
susceptibility
IAGP
DNA:polymorphisms:5' utr, exon:multiple (human)
RGD
PMID:15790942
RGD:1582150
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MMP3
matrix metallopeptidase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:8662692
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MMP7
matrix metallopeptidase 7
treatment
ISO
RGD
PMID:21139058
RGD:9685362
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
G
MTHFR
methylenetetrahydrofolate reductase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16489563
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
MYC
MYC proto-oncogene, bHLH transcription factor
treatment
ISO
RGD
PMID:7955204
RGD:10059621
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
NPY5R
neuropeptide Y receptor Y5
ISO
mRNA, protein:increased expression:carotid artery
RGD
PMID:12689918
RGD:1625501
NCBI chr 4:163,343,892...163,352,403
Ensembl chr 4:163,343,892...163,351,934
G
OAZ1
ornithine decarboxylase antizyme 1
susceptibility
IAGP
DNA:SNP:intron:c.2222A>G (rs2074458) (human)
RGD
PMID:17761941
RGD:401851037
NCBI chr19:2,269,486...2,273,488
Ensembl chr19:2,269,509...2,273,490
G
SPP1
secreted phosphoprotein 1
ISO IDA
RGD
PMID:12114325 PMID:16373617
RGD:1581358 , RGD:1581366
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
TNF
tumor necrosis factor
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16319143 PMID:16319143
RGD:1580322
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TP53
tumor protein p53
IAGP
RGD
PMID:14740296
RGD:1580742
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
UCP3
uncoupling protein 3
susceptibility
IAGP
DNA:polymorphism:promoter:-55C>T (human)
RGD
PMID:17786284
RGD:2313513
NCBI chr11:74,000,277...74,009,085
Ensembl chr11:74,000,277...74,009,085
G
APLN
apelin
IEP
protein:decreased expression:plasma
RGD
PMID:19015606
RGD:2313942
NCBI chr X:129,645,259...129,654,956
Ensembl chr X:129,645,259...129,654,956
G
CYP2R1
cytochrome P450 family 2 subfamily R member 1
IAGP
DNA:SNP:CDS: (Rs6486205|rs10741657|rs2060793)
RGD
PMID:34262949
RGD:401901074
NCBI chr11:14,877,440...14,892,443
Ensembl chr11:14,877,440...14,892,231
G
EDN1
endothelin 1
treatment
IDA
RGD
PMID:10854676
RGD:8661796
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
HRH2
histamine receptor H2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12721106
NCBI chr 5:175,658,071...175,710,756
Ensembl chr 5:175,658,030...175,710,756
G
IGF1
insulin like growth factor 1
ISO
mRNA:increased expression:myocyte:
RGD
PMID:8102103
RGD:10046053
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
ISO
mRNA:increased expression:myocyte:
RGD
PMID:8102103
RGD:10046053
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
ITGAV
integrin subunit alpha V
ISO
RGD
PMID:11922905
RGD:1582454
NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901
G
LMCD1
LIM and cysteine rich domains 1
IEP
protein:increased expression:coronary artery
RGD
PMID:32160773
RGD:243065232
NCBI chr 3:8,501,823...8,574,668
Ensembl chr 3:8,501,807...8,574,668
G
MDK
midkine
ISO
RGD
PMID:10683378
RGD:1299187
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
G
MYH7
myosin heavy chain 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12721106
NCBI chr14:23,412,740...23,435,660
Ensembl chr14:23,412,740...23,435,660
G
NPPA
natriuretic peptide A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12721106
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
G
PECAM1
platelet and endothelial cell adhesion molecule 1
IAGP
DNA:missense mutations:cds:p.L125V, p.S563N (human)
RGD
PMID:10571959
RGD:1598382
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PHACTR1
phosphatase and actin regulator 1
susceptibility
IAGP
DNA:SNP::g.13011943A>G (rs9349379) (human)
RGD
PMID:22745674
RGD:401900726
NCBI chr 6:12,716,767...13,287,837
Ensembl chr 6:12,716,312...13,290,446
G
PRKCE
protein kinase C epsilon
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16782078
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
G
TNFRSF11B
TNF receptor superfamily member 11b
IEP
protein:increased expression:serum
RGD
PMID:15569000
RGD:1624167
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
G
GP6
glycoprotein VI platelet
IAGP
DNA:missense mutation:CDS:c.13254T>C (human)
RGD
PMID:15306180
RGD:401793750
NCBI chr19:55,013,705...55,038,264
Ensembl chr19:55,013,705...55,038,264
G
ITGB3
integrin subunit beta 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:8598867
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
G
PLAT
plasminogen activator, tissue type
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:1452937 PMID:8172379 PMID:15301905
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
GSTM1
glutathione S-transferase mu 1
susceptibility
IAGP
DNA:deletion:cds: (human)
RGD
PMID:19279659
RGD:7495846
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
NOS3
nitric oxide synthase 3
IAGP
ClinVar Annotator: match by term: Hypertension resistant to conventional therapy
ClinVar
PMID:9737779 PMID:9894802 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 More...
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
PTPRD
protein tyrosine phosphatase receptor type D
susceptibility
IAGP
associated with coronary artery disease;DNA:SNP:intron: (rs324498) (human)
RGD
PMID:30237584
RGD:401976431
NCBI chr 9:8,314,246...10,613,002
Ensembl chr 9:8,314,246...10,613,002
G
ACE
angiotensin I converting enzyme
IEP
mRNA:increased expression:ventricular myocardium (human) mRNA:increased expression:myocardium
RGD
PMID:15131005 PMID:11451295
RGD:8142363 , RGD:8548894
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
AGT
angiotensinogen
IEP
mRNA:increased expression:myocardium
RGD
PMID:11451295
RGD:8548894
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AGTR1
angiotensin II receptor type 1
IEP
mRNA:increased expression:myocardium
RGD
PMID:11451295
RGD:8548894
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AKT1
AKT serine/threonine kinase 1
IEP
protein:increased serine phosphorylation:platelet
RGD
PMID:20467748
RGD:5509094
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
APOA4
apolipoprotein A4
IEP
protein:decreased expression:blood plasma (human)
RGD
PMID:20367977
RGD:5685646
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
BDNF
brain derived neurotrophic factor
IEP
RGD
PMID:16186425
RGD:4891111
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
CRP
C-reactive protein
disease_progression
IEP
RGD
PMID:9761079
RGD:9491780
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CXCL8
C-X-C motif chemokine ligand 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:10660968
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
EDN1
endothelin 1
IEP
associated with Coronary Artery Disease;protein:increased expression:coronary sinus, plasma (human)
RGD
PMID:14556009
RGD:8661755
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
F7
coagulation factor VII
IEP
protein:increased expression:plasma (human)
RGD
PMID:10653827
RGD:2312399
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
IMP
RGD
PMID:18333374
RGD:5508458
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
ITGA2
integrin subunit alpha 2
susceptibility
IAGP
RGD
PMID:15104219
RGD:1582303
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
ITGAM
integrin subunit alpha M
ameliorates
IEP
protein:decreased expression:neutrophil (human)
RGD
PMID:18043994
RGD:329901840
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
IDA
RGD
PMID:10486281
RGD:1582334
NCBI chr 3:52,812,962...52,830,672
Ensembl chr 3:52,812,962...52,830,688
G
MIR126
microRNA 126
disease_progression
IEP
RGD
PMID:32595526
RGD:401851053
NCBI chr 9:136,670,602...136,670,686
Ensembl chr 9:136,670,602...136,670,686
G
MIR21
microRNA 21
IEP
RNA:decreased expression:serum
RGD
PMID:32595526
RGD:401851053
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
G
MMP1
matrix metallopeptidase 1
IDA
RGD
PMID:14675588
RGD:1582536
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
PAPPA
pappalysin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11586954
NCBI chr 9:116,153,791...116,402,321
Ensembl chr 9:116,153,791...116,402,321
G
PLAU
plasminogen activator, urokinase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:2382605
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PTEN
phosphatase and tensin homolog
IEP
RNA:increased expression:serum
RGD
PMID:32595526
RGD:401851053
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
SELP
selectin P
IEP
protein:increased expression:serum
RGD
PMID:21162967
RGD:6219003
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
SERPINC1
serpin family C member 1
treatment
IDA
RGD
PMID:8122184
RGD:11035255
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
SOD3
superoxide dismutase 3
IEP
RGD
PMID:14592844
RGD:1580841
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
G
TXN
thioredoxin
IEP
RGD
PMID:15749180
RGD:1580784
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
ENPP1
ectonucleotide pyrophosphatase/phosphodiesterase 1
IAGP
ClinVar Annotator: match by term: Coronary sclerosis, medial, of infancy
ClinVar
PMID:9536098 PMID:15940697 PMID:17576681 PMID:25741868 PMID:28492532
NCBI chr 6:131,808,020...131,895,155
Ensembl chr 6:131,808,016...131,895,155
G
ABCC9
ATP binding cassette subfamily C member 9
IAGP
ClinVar Annotator: match by term: Myocardial infarction
ClinVar
PMID:16563363 PMID:18239147 PMID:20474083 PMID:21846889 PMID:23739550 PMID:23861362 PMID:24033266 PMID:24439875 PMID:25333069 PMID:25741868 PMID:26636822 PMID:26656175 PMID:26764160 PMID:28492532 More...
NCBI chr12:21,797,389...21,941,426
Ensembl chr12:21,797,389...21,942,543
G
ACE
angiotensin I converting enzyme
treatment susceptibility
IEA IAGP EXP ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism associated with Diabetes Mellitus, Type 1;DNA:deletion:intron:IVS16+1464-1751del (human) associated with Myocardial Reperfusion Injury
ClinVar CTD RGD
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:19221299 PMID:25741868 PMID:28492532 PMID:15118671 PMID:23959549 PMID:15671045 PMID:7555560 PMID:21975128 More...
RGD:1331525 , RGD:9685449 , RGD:1558664 , RGD:7829785 , RGD:6893480
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACE2
angiotensin converting enzyme 2
treatment
ISO
RGD
PMID:15671045 PMID:23959549
RGD:1558664 , RGD:9685449
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ACTA2
actin alpha 2, smooth muscle
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
G
ACVR2A
activin A receptor type 2A
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 2:147,844,517...147,930,822
Ensembl chr 2:147,844,517...147,930,826
G
ACVR2B
activin A receptor type 2B
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 3:38,453,890...38,493,142
Ensembl chr 3:38,453,890...38,493,142
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
RGD
PMID:15625312
RGD:9681751
NCBI chr21:26,835,755...26,845,409
Ensembl chr21:26,835,755...26,845,409
G
ADD1
adducin 1
no_association
IAGP
DNA:missense mutation:cds:p.G460W (human)
RGD
PMID:17082469 PMID:16420563
RGD:5147995 , RGD:5148001
NCBI chr 4:2,843,844...2,930,062
Ensembl chr 4:2,843,844...2,930,076
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
disease_progression
ISO
RGD
PMID:21326342
RGD:5686351
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADIPOR1
adiponectin receptor 1
ISO
mRNA, protein:decreased expression:heart left ventricle
RGD
PMID:16415076
RGD:1625764
NCBI chr 1:202,940,825...202,958,572
Ensembl chr 1:202,940,826...202,958,572
G
ADIPOR2
adiponectin receptor 2
ISO
mRNA, protein:decreased expression:heart left ventricle
RGD
PMID:16415076
RGD:1625764
NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674
G
ADORA1
adenosine A1 receptor
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:12160945
NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405
G
ADORA3
adenosine A3 receptor
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:12160945 PMID:20132822
NCBI chr 1:111,499,429...111,503,633
Ensembl chr 1:111,499,429...111,503,633
G
ADRA2B
adrenoceptor alpha 2B
IAGP
RGD
PMID:12535806
RGD:1559314
NCBI chr 2:96,112,876...96,116,571
Ensembl chr 2:96,112,876...96,116,571
G
ADRB1
adrenoceptor beta 1
IEA ISO
GAD RGD
PMID:15118671 PMID:17143192
RGD:1331525 , RGD:7241557
NCBI chr10:114,043,866...114,046,904
Ensembl chr10:114,043,866...114,046,904
G
ADRB2
adrenoceptor beta 2
susceptibility
IAGP ISO
DNA:polymorphisms: :p.G16R, p.Q27E, p.T164I mRNA:decreased expression:heart
RGD
PMID:15520258 PMID:12400771
RGD:1601126 , RGD:8548519
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
G
AGER
advanced glycosylation end-product specific receptor
susceptibility
ISO IAGP
mRNA:increased expression:left ventricle myocardium (rat) DNA:polymorphism:promoter:-429T>C (human)
RGD
PMID:19910580 PMID:16728681
RGD:2325647 , RGD:1625333
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AGT
angiotensinogen
susceptibility
ISO EXP IEA IAGP
CTD Direct Evidence: marker/mechanism associated with Coronary Artery Disease;DNA:polymorphism: :p.M235T (human) associated with hypertension;DNA:polymorphism: :p.M235T
CTD RGD
PMID:1668233 PMID:16413583 PMID:21167013 PMID:15118671 PMID:11393670 PMID:17299437 More...
RGD:5129191 , RGD:1331525 , RGD:1566452 , RGD:1601132
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AGTR1
angiotensin II receptor type 1
susceptibility no_association
IAGP ISO IEA
DNA:polymorphism:3' utr:1166A>C DNA:polymorphism:3' utr:1166A>C (human)
RGD GAD
PMID:16061119 PMID:9652322 PMID:15118671 PMID:9857918
RGD:1601150 , RGD:10047101 , RGD:1331525 , RGD:1566499
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AHSG
alpha 2-HS glycoprotein
IEP
protein:increased expression:plasma
RGD
PMID:19029462
RGD:2313810
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
G
AIMP1
aminoacyl tRNA synthetase complex interacting multifunctional protein 1
ISO
RGD
PMID:14732363
RGD:1580021
NCBI chr 4:106,315,544...106,349,456
Ensembl chr 4:106,315,544...106,349,456
G
AK1
adenylate kinase 1
treatment
ISO
RGD
PMID:22229508
RGD:11100025
NCBI chr 9:127,866,480...127,879,621
Ensembl chr 9:127,866,486...127,877,675
G
AKT1
AKT serine/threonine kinase 1
IEP ISO
protein:increased serine phosphorylation:platelet protein:decreased serine phosphorylation:heart
RGD
PMID:20467748 PMID:20352476
RGD:5509094 , RGD:10041035
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALDH2
aldehyde dehydrogenase 2 family member
IAGP
DNA:missense mutation: :p.E487K (human)
RGD
PMID:12452318
RGD:2311152
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
no_association
IAGP IEA
DNA:snps:multiple (human)
RGD GAD
PMID:14770184 PMID:15118671 PMID:19046748
RGD:1578317 , RGD:1331525 , RGD:2313891
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
G
ANG
angiogenin
IMP
RGD
PMID:18462761
RGD:2325719
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
G
ANGPT1
angiopoietin 1
ISO
mRNA, protein:decreased expression:myocardium
RGD
PMID:15364619
RGD:1626168
NCBI chr 8:107,249,482...107,497,918
Ensembl chr 8:107,249,482...107,498,055
G
ANGPT2
angiopoietin 2
ISO
protein:increased expression:left ventricular wall, heart septum (rat)
RGD
PMID:16714360
RGD:1601493
NCBI chr 8:6,499,632...6,563,245
Ensembl chr 8:6,499,632...6,563,409
G
ANXA5
annexin A5
susceptibility no_association
IAGP IEP ISO
DNA:polymorphism: :-1C>T (human) protein:increased expression:plasma protein:altered localization:cardiac muscle cell, sarcolemma
RGD
PMID:12200370 PMID:8814351 PMID:16025836 PMID:16501019
RGD:2317542 , RGD:2317543 , RGD:1578384 , RGD:2317541
NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
G
APEX1
apurinic/apyrimidinic endodeoxyribonuclease 1
susceptibility
IAGP
DNA:polymorphism:exon 5: G>A (human)
RGD
PMID:18712175
RGD:401827276
NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
G
APOA1
apolipoprotein A1
no_association
IDA IEA IAGP
DNA:polymorphisms
RGD GAD
PMID:20176799 PMID:15118671 PMID:10428310
RGD:2325759 , RGD:1331525 , RGD:1578442
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
G
APOA4
apolipoprotein A4
susceptibility no_association
IEA IAGP
associated with Diabetes Mellitus, Type 2; DNA:missense mutation:cds:p.Q360H (human) DNA:mutation:intron:IVS2 (human)
GAD RGD
PMID:15118671 PMID:7958503 PMID:10428310
RGD:1331525 , RGD:5685678 , RGD:1578442
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
APOB
apolipoprotein B
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
G
APOC3
apolipoprotein C3
no_association
IAGP IEA
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar RGD
PMID:10428310 PMID:15118671
RGD:1578442 , RGD:1331525
NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
G
APOE
apolipoprotein E
susceptibility
IAGP EXP IEA
DNA:missense mutations, haplotypes:cds:p.C112R, p.R158C (human) CTD Direct Evidence: marker/mechanism DNA:missense mutations, haplotype:cds:p.C112R, p.C158R (human)
CTD RGD
PMID:10587578 PMID:17217375 PMID:10090925 PMID:15118671
RGD:1601229 , RGD:10449412 , RGD:1331525
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
APOH
apolipoprotein H
IDA ISO
RGD
PMID:15322656 PMID:12826288
RGD:2313985 , RGD:10054111
NCBI chr17:66,212,033...66,229,415
Ensembl chr17:66,212,033...66,256,525
G
ATG7
autophagy related 7
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
G
ATM
ATM serine/threonine kinase
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24358288 PMID:24358288
RGD:10053570
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,823...108,369,102
G
ATP1A1
ATPase Na+/K+ transporting subunit alpha 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29702141
NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261
G
ATP5F1D
ATP synthase F1 subunit delta
treatment
ISO
protein:decreased expression:myocardium (rat)
RGD
PMID:29300489 PMID:23809007
RGD:13792656 , RGD:13792681
NCBI chr19:1,241,751...1,244,825
Ensembl chr19:1,241,746...1,244,825
G
ATP5PO
ATP synthase peripheral stalk subunit OSCP
treatment
ISO
RGD
PMID:24692845
RGD:13801194
NCBI chr21:33,903,453...33,915,804
Ensembl chr21:33,903,453...33,915,814
G
AVPR1A
arginine vasopressin receptor 1A
ISO
RGD
PMID:16423716
RGD:2300376
NCBI chr12:63,142,759...63,151,201
Ensembl chr12:63,142,759...63,151,201
G
BAK1
BCL2 antagonist/killer 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29122578
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
G
BAX
BCL2 associated X, apoptosis regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20079142 PMID:25450231
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20079142 PMID:17467744
RGD:1643494
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BDKRB1
bradykinin receptor B1
ISO
mRNA:increased expression:heart
RGD
PMID:12489796
RGD:704379
NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967
G
BDKRB2
bradykinin receptor B2
ISO
mRNA:increased expression:heart
RGD
PMID:12489796
RGD:704379
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
BECN1
beclin 1
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20079142 PMID:20079142
RGD:11561913
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
BIRC5
baculoviral IAP repeat containing 5
ISO
RGD
PMID:15081314
RGD:2293137
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
G
BNIP3
BCL2 interacting protein 3
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
G
BRAP
BRCA1 associated protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198608
NCBI chr12:111,642,146...111,685,956
Ensembl chr12:111,642,146...111,685,956
G
BRINP3
BMP/retinoic acid inducible neural specific 3
susceptibility
IAGP
DNA:SNPs:3' end:
RGD
PMID:18430236
RGD:14398488
NCBI chr 1:190,097,658...190,477,864
Ensembl chr 1:190,097,658...190,478,404
G
C3
complement C3
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:16996480
RGD:1600605
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C7
complement C7
ISO
Protein:increased activity:serum, myocardium
RGD
PMID:15724448
RGD:1599522
NCBI chr 5:40,909,497...40,984,643
Ensembl chr 5:40,909,492...41,020,216
G
C8A
complement C8 alpha chain
ISO
RGD
PMID:7515561
RGD:1600501
NCBI chr 1:56,854,797...56,918,223
Ensembl chr 1:56,854,768...56,918,223
G
C8B
complement C8 beta chain
ISO
RGD
PMID:7515561
RGD:1600501
NCBI chr 1:56,929,207...56,966,015
Ensembl chr 1:56,929,207...56,974,383
G
CACYBP
calcyclin binding protein
ISO
mRNA:increased expression:heart
RGD
PMID:16440310
RGD:2326117
NCBI chr 1:174,999,435...175,012,027
Ensembl chr 1:174,999,163...175,012,027
G
CAMK2D
calcium/calmodulin dependent protein kinase II delta
treatment
ISO
mRNA, protein:splice variants, increased expression:heart left ventricle (rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr 4:113,451,032...113,761,738
Ensembl chr 4:113,418,054...113,761,927
G
CASP1
caspase 1
severity ameliorates
ISO
RGD
PMID:17303764 PMID:33389498
RGD:2315913 , RGD:242905187
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CASP3
caspase 3
ameliorates treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25450231 PMID:28622474 PMID:27904666
RGD:329333030 , RGD:13782309
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASR
calcium sensing receptor
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:22527939
RGD:7205672
NCBI chr 3:122,183,668...122,291,629
Ensembl chr 3:122,183,668...122,291,629
G
CAT
catalase
ISO EXP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21600015 PMID:14575298
RGD:1581148
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CAV3
caveolin 3
ISO
Protein:increased expression:cytosol mRNA, protein; increased expression; myocardium (rat)
RGD
PMID:12566108 PMID:29438664
RGD:1599542 , RGD:126925221
NCBI chr 3:8,733,802...8,746,758
Ensembl chr 3:8,733,802...8,841,808
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO IAGP
protein:increased expression:serum DNA:snp:promoter:g.-2518A>G (human)
RGD
PMID:18459941 PMID:18753699 PMID:16116069
RGD:2307033 , RGD:8549616 , RGD:1581161
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:heart (rat)
RGD
PMID:18954648
RGD:4890013
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCN1
cellular communication network factor 1
ISO
mRNA,protein:increased expression:myocardium (mouse)
RGD
PMID:15117851
RGD:329845570
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
CCN2
cellular communication network factor 2
treatment
ISO
mRNA:increased expression:left ventricle (rat)
RGD
PMID:18167060 PMID:29849775
RGD:2314623 , RGD:35673318
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CCNA2
cyclin A2
ISO
protein:increased expression:cardiomyocyte:
RGD
PMID:23634243
RGD:10054471
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
G
CCR2
C-C motif chemokine receptor 2
IAGP
RGD
PMID:12719858 PMID:12853162
RGD:1581177 , RGD:1581174
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:18954648
RGD:4890013
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CCT7
chaperonin containing TCP1 subunit 7
IAGP
ClinVar Annotator: match by term: MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1
ClinVar
PMID:24213632
NCBI chr 2:73,234,308...73,253,005
Ensembl chr 2:73,233,420...73,253,021
G
CD14
CD14 molecule
no_association
IAGP
associated with Coronary Artery Disease;DNA:SNP:promoter
RGD
PMID:17436151 PMID:10195920 PMID:14587643
RGD:2314155 , RGD:1580252 , RGD:1580255
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD36
CD36 molecule (CD36 blood group)
severity
ISO
RGD
PMID:22128087
RGD:6893560
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
CD40LG
CD40 ligand
IEP
protein:increased expression:serum
RGD
PMID:17635572
RGD:2314209
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
G
CD59
CD59 molecule (CD59 blood group)
ISO
protein:decreased expression:myocardium
RGD
PMID:7515561
RGD:1600501
NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
G
CDKN1B
cyclin dependent kinase inhibitor 1B
treatment
ISO
RGD
PMID:22492676 PMID:22492676
RGD:10045366 , RGD:10045366
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CFL1
cofilin 1
treatment
ISO
RGD
PMID:24292258
RGD:11570534
NCBI chr11:65,854,673...65,858,180
Ensembl chr11:65,823,022...65,862,026
G
CFTR
CF transmembrane conductance regulator
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:23221371
RGD:11566046
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
CHI3L1
chitinase 3 like 1
IEP
protein:increased secretion:serum (human)
RGD
PMID:18480670
RGD:4892633
NCBI chr 1:203,178,931...203,186,704
Ensembl chr 1:203,178,931...203,186,704
G
CIITA
class II major histocompatibility complex transactivator
susceptibility no_association
IAGP
DNA:polymorphism:promoter:-168A>G
RGD
PMID:15821736 PMID:17183695
RGD:1358146 , RGD:5491201
NCBI chr16:10,866,206...10,943,021
Ensembl chr16:10,866,222...10,943,021
G
CKB
creatine kinase B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12359538
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
G
CKM
creatine kinase, M-type
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:3279722 PMID:12359538
NCBI chr19:45,306,413...45,322,875
Ensembl chr19:45,306,413...45,322,875
G
CLU
clusterin
treatment
IDA
RGD
PMID:20854280
RGD:9068409
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
COL1A1
collagen type I alpha 1 chain
treatment
ISO
RGD
PMID:25636075
RGD:11041598
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL3A1
collagen type III alpha 1 chain
treatment
ISO
RGD
PMID:25636075
RGD:11041598
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
G
COL4A1
collagen type IV alpha 1 chain
susceptibility
IAGP
DNA:polymorphism: :p.Q1334H (human)
RGD
PMID:18077766
RGD:2311341
NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,157
G
COL6A3
collagen type VI alpha 3 chain
IAGP
DNA:SNP:CDS:E1386K (rs146092501) (human)
RGD
PMID:30226566
RGD:401851058
NCBI chr 2:237,324,018...237,414,164
Ensembl chr 2:237,324,003...237,414,328
G
CREB1
cAMP responsive element binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CREM
cAMP responsive element modulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
G
CRP
C-reactive protein
ISO IEP
protein:increased expression:serum associated with Angina, Unstable;
RGD
PMID:21046814 PMID:9761079 PMID:22446866
RGD:5131456 , RGD:9491780 , RGD:6482304
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CS
citrate synthase
severity
ISO
protein:decreased expression:diaphragm, mitochondrion
RGD
PMID:1877670 PMID:34416105
RGD:243048469 , RGD:243048471
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
G
CSF2
colony stimulating factor 2
ISO
RGD
PMID:21326109
RGD:5131507
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CSF3
colony stimulating factor 3
treatment
IDA
RGD
PMID:15639484
RGD:11039417
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
CSNK2A1
casein kinase 2 alpha 1
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr20:472,498...543,790
Ensembl chr20:472,498...543,835
G
CSNK2B
casein kinase 2 beta
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr 6:31,666,080...31,670,067
Ensembl chr 6:31,665,227...31,670,343
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
IAGP
DNA:SNP:CDS:49A>G (human)
RGD
PMID:17652883
RGD:2301976
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CTSB
cathepsin B
ISO
protein:increased activity:serum, heart (rat)
RGD
PMID:19958779
RGD:2315501
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
mRNA:increased expression:heart left ventricle
RGD
PMID:19187644 PMID:11820456
RGD:2306567 , RGD:632503
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
G
CYBA
cytochrome b-245 alpha chain
ISO
mRNA:increased expression:myocardium mRNA:increase expression:ventricle myocardium:
RGD
PMID:18762777 PMID:11243862
RGD:2317860 , RGD:1599690
NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
G
CYBB
cytochrome b-245 beta chain
ISO
mRNA:increase expression:ventricle myocardium
RGD
PMID:11243862
RGD:1599690
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
G
CYP11B1
cytochrome P450 family 11 subfamily B member 1
ISO
RGD
PMID:18689429
RGD:2307303
NCBI chr 8:142,872,357...142,879,825
Ensembl chr 8:142,872,356...142,879,846
G
CYP11B2
cytochrome P450 family 11 subfamily B member 2
ISO
RGD
PMID:18689429
RGD:2307303
NCBI chr 8:142,910,559...142,917,843
Ensembl chr 8:142,910,559...142,917,843
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP2J2
cytochrome P450 family 2 subfamily J member 2
susceptibility
IAGP
DNA:polymorphism
RGD
PMID:17126841
RGD:1625380
NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,773
G
CYP2R1
cytochrome P450 family 2 subfamily R member 1
IAGP
DNA:SNP:CDS:rs2060793, rs1993116, rs10766197 (human)
RGD
PMID:29804528
RGD:401901167
NCBI chr11:14,877,440...14,892,443
Ensembl chr11:14,877,440...14,892,231
G
DAB2
DAB adaptor protein 2
ISO
protein:increased expression:cardiomyocyte
RGD
PMID:20666606 PMID:21762377
RGD:7243156 RGD:7243158
NCBI chr 5:39,371,677...39,424,980
Ensembl chr 5:39,371,675...39,462,300
G
DAB2IP
DAB2 interacting protein
onset
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:SNP:CDS:intron 1 (rs7025486) (human)
CTD RGD
PMID:20622881 PMID:20622881
RGD:401901599
NCBI chr 9:121,567,074...121,785,530
Ensembl chr 9:121,567,057...121,785,530
G
DAG1
dystroglycan 1
treatment
ISO
RGD
PMID:12034665
RGD:11541047
NCBI chr 3:49,468,948...49,535,615
Ensembl chr 3:49,468,713...49,535,618
G
DCN
decorin
ISO
RGD
PMID:16311904
RGD:1598497
NCBI chr12:91,140,484...91,182,817
Ensembl chr12:91,140,484...91,183,217
G
DDIT3
DNA damage inducible transcript 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25450231
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DGKZ
diacylglycerol kinase zeta
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:17071729
NCBI chr11:46,332,926...46,380,554
Ensembl chr11:46,332,905...46,380,554
G
DVL1
dishevelled segment polarity protein 1
ISO
RGD
PMID:15256074
RGD:1580899
NCBI chr 1:1,335,278...1,349,418
Ensembl chr 1:1,335,276...1,349,418
G
DYRK1A
dual specificity tyrosine phosphorylation regulated kinase 1A
treatment
ISO
associated with heart failure; protein:increased expression, increased activity:heart left ventricle (rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr21:37,365,573...37,526,358
Ensembl chr21:37,365,573...37,526,358
G
ECE1
endothelin converting enzyme 1
IEP
RGD
PMID:9607404
RGD:1580912
NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572
G
EDN1
endothelin 1
severity
IEP ISO
protein:increased secretion:plasma (human) mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:17893002 PMID:10573185
RGD:4144880 , RGD:1580921
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
EDN2
endothelin 2
ISO
RGD
PMID:10573185
RGD:1580921
NCBI chr 1:41,478,775...41,484,683
Ensembl chr 1:41,478,775...41,484,683
G
EDNRA
endothelin receptor type A
ISO
RGD
PMID:12524016
RGD:1580948
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
G
EDNRB
endothelin receptor type B
ISO
RGD
PMID:12524016
RGD:1580948
NCBI chr13:77,895,481...77,975,527
Ensembl chr13:77,895,481...77,975,529
G
EGLN1
egl-9 family hypoxia inducible factor 1
ISO
RGD
PMID:16765982
RGD:11252084
NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287
G
EGLN3
egl-9 family hypoxia inducible factor 3
ISO
RGD
PMID:16765982
RGD:11252084
NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774
G
EPAS1
endothelial PAS domain protein 1
ISO
RGD
PMID:15247145 PMID:18484163
RGD:1580977 , RGD:5147886
NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
G
EPHB1
EPH receptor B1
ameliorates
ISO
RGD
PMID:28622474
RGD:329333030
NCBI chr 3:134,795,260...135,260,467
Ensembl chr 3:134,795,260...135,260,467
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:19716829
RGD:5688358
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
EPO
erythropoietin
treatment
IDA EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19337937 PMID:21415704
RGD:10400907
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
G
EPOR
erythropoietin receptor
ISO
RGD
PMID:21415704
RGD:10400907
NCBI chr19:11,377,207...11,384,314
Ensembl chr19:11,377,207...11,384,342
G
ESR1
estrogen receptor 1
susceptibility
IEA IAGP EXP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:11894143 PMID:11919305 PMID:14600184 PMID:15133719 PMID:25741868 PMID:15118671 More...
RGD:1331525
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
F10
coagulation factor X
IAGP
ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to
ClinVar
PMID:10984565 PMID:12181036 PMID:25741868
NCBI chr13:113,122,799...113,149,529
Ensembl chr13:113,122,799...113,149,529
G
F12
coagulation factor XII
susceptibility
IAGP
DNA:polymorphism:promoter:-46C>T(human)
RGD
PMID:16411408
RGD:11041803
NCBI chr 5:177,402,141...177,409,564
Ensembl chr 5:177,402,133...177,416,583
G
F13A1
coagulation factor XIII A chain
IAGP EXP
ClinVar Annotator: match by term: Myocardial infarction, protection against CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:8025280 PMID:9459313 PMID:9550516 PMID:10365735 PMID:10910914 PMID:12072871 PMID:12456499 PMID:17393027 PMID:25741868 PMID:12480694 More...
RGD:1581022
NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013
G
F2
coagulation factor II, thrombin
susceptibility
IAGP EXP
DNA:polymorphism::20210G>A(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9292507 PMID:9531249 PMID:10027711 PMID:12480694
RGD:1581022
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
F3
coagulation factor III, tissue factor
treatment
ISO
RGD
PMID:21229253
RGD:11062083
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
F5
coagulation factor V
susceptibility no_association
IAGP EXP
DNA:mutation:cds:1691G>A (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9531249 PMID:15131548 PMID:10590188
RGD:11564335 , RGD:11564337
NCBI chr 1:169,511,951...169,586,481
Ensembl chr 1:169,511,951...169,586,588
G
F7
coagulation factor VII
susceptibility
IAGP EXP IEP
ClinVar Annotator: match by term: F7-related condition ClinVar Annotator: match by term: F7-related condition | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to DNA:missense mutation, repeat:cds, intron:p.R353Q, (human) protein:increased activity:plasma (human)
OMIM ClinVar CTD RGD
PMID:1634227 PMID:2070047 PMID:6812354 PMID:7919338 PMID:7981691 PMID:8242057 PMID:8844208 PMID:8883260 PMID:10554827 PMID:10862079 PMID:10984565 PMID:11129332 PMID:11931672 PMID:12181036 PMID:12903033 PMID:12935978 PMID:15142120 PMID:15456489 PMID:15735798 PMID:18282149 PMID:18669152 PMID:18976247 PMID:20040857 PMID:20735728 PMID:20958793 PMID:21902896 PMID:22180436 PMID:25582404 PMID:25741868 PMID:25741916 PMID:25828579 PMID:25952977 PMID:26105150 PMID:28492532 PMID:31064749 PMID:34355501 PMID:16116695 PMID:9420338 PMID:7495060 More...
RGD:1580374 , RGD:11049521 , RGD:2312409
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
G
FABP3
fatty acid binding protein 3
IEP
RGD
PMID:8326460
RGD:1582401
NCBI chr 1:31,359,588...31,373,076
Ensembl chr 1:31,365,253...31,376,850
G
FGB
fibrinogen beta chain
IAGP IEA
RGD GAD
PMID:9437197 PMID:15118671
RGD:1580381 , RGD:1331525
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
G
FGF1
fibroblast growth factor 1
treatment
IDA
RGD
PMID:24200746
RGD:10449026
NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070
G
FGFR1
fibroblast growth factor receptor 1
ISO
RGD
PMID:17439742
RGD:10402087
NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
G
FGFR2
fibroblast growth factor receptor 2
ameliorates
ISO
RGD
PMID:19358330
RGD:155663664
NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458
G
FIS1
fission, mitochondrial 1
ISO
protein:increased expression:plantaris (rat)
RGD
PMID:24427319
RGD:11557988
NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316
G
FLT1
fms related receptor tyrosine kinase 1
ISO
RGD
PMID:16714360
RGD:1601493
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
G
FLT3LG
fms related receptor tyrosine kinase 3 ligand
treatment
ISO
RGD
PMID:24184252
RGD:11049498
NCBI chr19:49,474,215...49,486,231
Ensembl chr19:49,474,207...49,486,231
G
FN1
fibronectin 1
ISO
protein:decreased expression:heart
RGD
PMID:19695229
RGD:2325720
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
treatment
ISO IAGP
mRNA, protein:decreased expression:heart DNA:SNP: :rs17817449 (human) associated with type 2 diabetes mellitus;DNA:SNP:intron:rs9939609 (human)
RGD
PMID:29997116 PMID:26772723 PMID:20031593 PMID:29997116
RGD:329812009 , RGD:11555187 , RGD:329901766 , RGD:329812009
NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
G
FZD2
frizzled class receptor 2
ISO
mRNA:increased expression:heart left ventricle
RGD
PMID:9142123
RGD:4107058
NCBI chr17:44,557,484...44,561,262
Ensembl chr17:44,557,484...44,561,262
G
G6PD
glucose-6-phosphate dehydrogenase
treatment
ISO
RGD
PMID:20462747
RGD:10449173
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GATA4
GATA binding protein 4
treatment
ISO EXP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:20200331 PMID:23948075
RGD:7327215
NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,959...11,760,002
G
GATM
glycine amidinotransferase
ISO
RGD
PMID:31972362
RGD:329961305
NCBI chr15:45,361,124...45,402,227
Ensembl chr15:45,361,124...45,402,327
G
GCH1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:32782412 PMID:26192027
RGD:329961570 , RGD:329970290
NCBI chr14:54,842,017...54,902,826
Ensembl chr14:54,842,008...54,902,826
G
GCLC
glutamate-cysteine ligase catalytic subunit
IAGP EXP
DNA:snp:promoter:c.-129C>T (human) ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:12598062 PMID:12598062
RGD:1302515
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:12081989 PMID:12975258
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GGT1
gamma-glutamyltransferase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19419996
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GH1
growth hormone 1
treatment
IDA
RGD
PMID:12500159
RGD:11352745
NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
G
GHRH
growth hormone releasing hormone
treatment
ISO
RGD
PMID:24373935
RGD:10401242
NCBI chr20:37,251,086...37,261,814
Ensembl chr20:37,251,086...37,261,819
G
GJA1
gap junction protein alpha 1
treatment
ISO
protein:decreased phosphorylation
RGD
PMID:22969867 PMID:29428663 PMID:22841862
RGD:7207261 , RGD:13592597 , RGD:7207262
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GJA4
gap junction protein alpha 4
IAGP
DNA:SNP:CDS:T allele of 1019C>T in Japanese men (p<0.001) associated with coronary artery disease; DNA:SNP:CDS:C allele of 1019C>T, amino acid P319S (p = 0.0026) in a Swiss population
RGD
PMID:12477941 PMID:15982495 PMID:16677656
RGD:1626626 , RGD:1580400 , RGD:1626615
NCBI chr 1:34,792,999...34,795,747
Ensembl chr 1:34,792,999...34,795,747
G
GJA5
gap junction protein alpha 5
treatment
ISO
RGD
PMID:29428663
RGD:13592597
NCBI chr 1:147,756,199...147,773,351
Ensembl chr 1:147,756,199...147,773,362
G
GP1BA
glycoprotein Ib platelet subunit alpha
IAGP
RGD
PMID:15269835
RGD:1580432
NCBI chr17:4,932,277...4,935,023
Ensembl chr17:4,932,277...4,935,023
G
GP6
glycoprotein VI platelet
sexual_dimorphism treatment no_association susceptibility onset
IAGP IMP
DNA:missense mutation:CDS:c.13254T>C (p.S219P) (human) human protein in a mouse model DNA:missense mutation:CDS:c.13254T>C (p.S219P) (rs1613662) (human) DNA:missense mutation:exon 7:c.645213C>T (p.T249A) (human) DNA:SNP, missense mutation:promoter, CDS:c.-148C>T, c.13254T>C (p.S219P) (human)
RGD
PMID:11571236 PMID:22814400 PMID:20723028 PMID:12417295 PMID:11571236 PMID:11571236 More...
RGD:401793749 , RGD:401824647 , RGD:401794407 , RGD:401793754 , RGD:401793749 , RGD:401793749
NCBI chr19:55,013,705...55,038,264
Ensembl chr19:55,013,705...55,038,264
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:32026788
RGD:401793703
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPX1
glutathione peroxidase 1
susceptibility
IEP
RGD
PMID:14573732
RGD:1600662
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GSK3B
glycogen synthase kinase 3 beta
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16716347 PMID:16565311
RGD:10045368
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
GSN
gelsolin
ameliorates
IEP ISO
protein:decreased expression:blood serum (human)
RGD
PMID:9142022 PMID:28622474
RGD:329333022 , RGD:329333030
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:25119867
RGD:10401898
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GUCY1A1
guanylate cyclase 1 soluble subunit alpha 1
IAGP
ClinVar Annotator: match by term: MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1
ClinVar
PMID:24213632
NCBI chr 4:155,666,848...155,737,059
Ensembl chr 4:155,666,726...155,737,059
G
H19
H19 imprinted maternally expressed transcript
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr11:1,995,176...2,001,466
Ensembl chr11:1,995,166...2,004,552
G
HADH
hydroxyacyl-CoA dehydrogenase
ISO
RGD
PMID:11481570
RGD:2302229
NCBI chr 4:107,989,889...108,035,171
Ensembl chr 4:107,989,714...108,035,241
G
HAMP
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:heart
RGD
PMID:19615879
RGD:11041636
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
G
HFE
homeostatic iron regulator
susceptibility no_association
IAGP
RGD
PMID:10491370 PMID:12850485
RGD:1582697 , RGD:1582672
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,281...26,098,343
G
HGF
hepatocyte growth factor
treatment
IEP IDA
protein:increased expression:serum:
RGD
PMID:12419930 PMID:16570015
RGD:8548609 , RGD:8548632
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ameliorates treatment
ISO IMP
mRNA:increased expression:heart left ventricle human gene in a rat model
RGD
PMID:18484163 PMID:28622474 PMID:15247145 PMID:15999059
RGD:5147886 , RGD:329333030 , RGD:1580977 , RGD:9068466
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HMGB1
high mobility group box 1
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21113057 PMID:23188125
RGD:10402174
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:12392996 PMID:20925964
RGD:1598393 , RGD:4145134
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HP
haptoglobin
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16597321 PMID:17068284 PMID:17207726 PMID:3990081 PMID:2613263
RGD:1626360 , RGD:1626354
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
ameliorates
ISO
RGD
PMID:28522730 PMID:26465199
RGD:329902054 , RGD:11087531
NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO EXP
mRNA:increased expression:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17587755 PMID:17587755
RGD:2308939
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
HSPA5
heat shock protein family A (Hsp70) member 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25450231
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPD1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:17202668
RGD:1624230
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10070497 PMID:23139358
RGD:8547733
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNA2
interferon alpha 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:3597002
NCBI chr 9:21,384,255...21,385,398
Ensembl chr 9:21,384,255...21,385,398
G
IGF1
insulin like growth factor 1
severity
ISO IAGP
mRNA, protein:increased expression:myocardium
RGD
PMID:19295919 PMID:16635594
RGD:2306696 , RGD:1598421
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
ISO
mRNA,protein:increased expression:myocyte:
RGD
PMID:8682060
RGD:10046050
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
IL10
interleukin 10
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15883752 PMID:16310260 PMID:15466015
RGD:1598480
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL17A
interleukin 17A
ISO
mRNA, protein:increased expression:heart left ventricle (rat)
RGD
PMID:23096364
RGD:9095344
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL18BP
interleukin 18 binding protein
IDA
RGD
PMID:19805173
RGD:4889400
NCBI chr11:71,998,909...72,008,200
Ensembl chr11:71,998,613...72,007,315
G
IL1B
interleukin 1 beta
ameliorates
ISO EXP
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:11743230 PMID:15883752 PMID:16310260 PMID:23143013 PMID:33389498 PMID:23237935 More...
RGD:7175553 , RGD:242905187 , RGD:7204425
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:18474815 PMID:19005744
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL4R
interleukin 4 receptor
ISO
mRNA:increased expression:heart
RGD
PMID:10807530
RGD:4889985
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL6
interleukin 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15883752 PMID:16310260
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6R
interleukin 6 receptor
ISO
RGD
PMID:12123772
RGD:1625444
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
G
INHBA
inhibin subunit beta A
ISO
mRNA:increased expression:heart (rat) mRNA:increased expression:myocardium (mouse)
RGD
PMID:14993131 PMID:32427381
RGD:1580888 , RGD:329849118
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
G
INHBB
inhibin subunit beta B
ISO
mRNA:increased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 2:120,346,136...120,351,803
Ensembl chr 2:120,346,136...120,351,803
G
ISL1
ISL LIM homeobox 1
ameliorates
IDA ISO
RGD
PMID:29482621 PMID:22727192
RGD:243048463 , RGD:243048464
NCBI chr 5:51,383,448...51,394,730
Ensembl chr 5:51,383,448...51,394,730
G
ITGA2
integrin subunit alpha 2
susceptibility no_association
IAGP
RGD
PMID:16697311 PMID:10194421 PMID:15227729
RGD:1582296 , RGD:1581029 , RGD:1582294
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
ITGA3
integrin subunit alpha 3
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:19041328
RGD:2325287
NCBI chr17:50,056,110...50,090,481
Ensembl chr17:50,055,968...50,090,481
G
ITGAM
integrin subunit alpha M
treatment
ISO
RGD
PMID:29933226
RGD:329853753
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
ITGB1
integrin subunit beta 1
treatment
ISO
RGD
PMID:28367125
RGD:13602094
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
G
ITGB3
integrin subunit beta 3
no_association susceptibility
IAGP EXP
DNA:polymorphism:exon: ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism associated with arteriosclerosis; DNA:polymorphism:exon
OMIM ClinVar CTD RGD
PMID:2014236 PMID:7570918 PMID:8598867 PMID:8667943 PMID:8838346 PMID:9700201 PMID:10583927 PMID:10727448 PMID:11723016 PMID:17264806 PMID:25728920 PMID:25741868 PMID:28492532 PMID:9716140 PMID:10531147 PMID:20846430 More...
RGD:5128498 , RGD:5128481 , RGD:5128476
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
IDA
RGD
PMID:10486281
RGD:1582334
NCBI chr 3:52,812,962...52,830,672
Ensembl chr 3:52,812,962...52,830,688
G
JAK2
Janus kinase 2
susceptibility
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:22749532
RGD:10403083
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
KCNJ2
potassium inwardly rectifying channel subfamily J member 2
treatment
ISO
RGD
PMID:23647964
RGD:7247426
NCBI chr17:70,169,532...70,180,044
Ensembl chr17:70,168,673...70,180,044
G
KCNK2
potassium two pore domain channel subfamily K member 2
ISO
mRNA:decreased expression:heart left ventricle, epicardium, endocardium (rat)
RGD
PMID:21683547
RGD:9831182
NCBI chr 1:215,005,542...215,237,090
Ensembl chr 1:215,005,775...215,237,090
G
KCNN4
potassium calcium-activated channel subfamily N member 4
susceptibility
IAGP
DNA:SNPs,haplotypes:introns:multiple
RGD
PMID:19644414
RGD:329969896
NCBI chr19:43,766,533...43,780,973
Ensembl chr19:43,766,533...43,780,976
G
KDM5B
lysine demethylase 5B
ameliorates
ISO
RGD
PMID:36481938
RGD:329901769
NCBI chr 1:202,724,495...202,808,421
Ensembl chr 1:202,724,495...202,808,487
G
KDM6A
lysine demethylase 6A
ISO
mRNA:increased expression:myocardium (rat)
RGD
PMID:30887465
RGD:151665136
NCBI chr X:44,873,188...45,112,779
Ensembl chr X:44,873,188...45,112,779
G
KDR
kinase insert domain receptor
treatment
IDA ISO
RGD
PMID:16698275 PMID:25936512
RGD:1581717 , RGD:126925214
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
KIF6
kinesin family member 6
no_association treatment
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:SNP: :p.W719R (rs20455) (human) DNA:SNP: :rs20455 (human)
CTD RGD
PMID:21943003 PMID:20927332 PMID:26997531 PMID:19371834 PMID:20403483 PMID:18222354 More...
RGD:243048450 , RGD:243048449 , RGD:243048447 , RGD:11097528 , RGD:243048446
NCBI chr 6:39,329,990...39,725,408
Ensembl chr 6:39,329,990...39,725,408
G
KLF13
KLF transcription factor 13
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29122578
NCBI chr15:31,326,835...31,435,665
Ensembl chr15:31,326,835...31,435,665
G
KLK1
kallikrein 1
IAGP EXP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12411458 PMID:17022964
RGD:1641799
NCBI chr19:50,819,146...50,823,787
Ensembl chr19:50,819,146...50,823,787
G
LAMP2
lysosomal associated membrane protein 2
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr X:120,426,148...120,469,349
Ensembl chr X:120,426,148...120,469,365
G
LCAT
lecithin-cholesterol acyltransferase
ISO
RGD
PMID:16640830
RGD:1581773
NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
G
LCN2
lipocalin 2
ameliorates
ISO
RGD
PMID:27800610
RGD:126790572
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
G
LDHA
lactate dehydrogenase A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:3279722
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
G
LDLR
low density lipoprotein receptor
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LEFTY1
left-right determination factor 1
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr 1:225,886,282...225,889,146
Ensembl chr 1:225,886,282...225,911,382
G
LGALS2
galectin 2
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
OMIM CTD ClinVar RGD
PMID:15129282 PMID:15129282
RGD:1581852
NCBI chr22:37,570,248...37,580,087
Ensembl chr22:37,570,248...37,582,616
G
LGALS3
galectin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29769800
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
G
LINC01588
long intergenic non-protein coding RNA 1588
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:35258167
NCBI chr14:49,981,669...50,007,520
Ensembl chr14:49,927,571...50,105,102
G
LIPG
lipase G, endothelial type
susceptibility
IAGP
DNA:polymorphism: :584C>T (human)
RGD
PMID:17526978
RGD:1641818
NCBI chr18:49,561,479...49,599,185
Ensembl chr18:49,560,699...49,599,185
G
LOC100287329
uncharacterized LOC100287329
IAGP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar
PMID:12426569 PMID:12746914 PMID:14681301
NCBI chr 6:31,559,571...31,572,703
G
LOC129930970
ATAC-STARR-seq lymphoblastoid silent region 1091
IAGP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar
PMID:12081989 PMID:12975258
G
LOX
lysyl oxidase
ISO
RGD
PMID:14553832
RGD:1581883
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LPA
lipoprotein(a)
IAGP
DNA:SNP:CDS:rs3798220, g.160961137T>C, p.Ile1891Met
RGD
PMID:18775538
RGD:5509091
NCBI chr 6:160,531,482...160,664,275
Ensembl chr 6:160,531,482...160,664,275
G
LPL
lipoprotein lipase
susceptibility
IAGP
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:SNP: :p.D9N (rs1801177) (human)
RGD
PMID:18823627
RGD:2313302
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
LRP1
LDL receptor related protein 1
susceptibility
IAGP
RGD
PMID:12402342
RGD:1581913
NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361
G
LRP8
LDL receptor related protein 8
onset susceptibility no_association
IAGP EXP
DNA:missense mutation:cds:p.R952Q (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1
CTD OMIM ClinVar RGD
PMID:17847002 PMID:17847002 PMID:18592168
RGD:2306124 , RGD:2306125
NCBI chr 1:53,242,364...53,328,070
Ensembl chr 1:53,242,364...53,328,469
G
LRPAP1
LDL receptor related protein associated protein 1
susceptibility
IAGP
RGD
PMID:12394648
RGD:1581922
NCBI chr 4:3,503,612...3,532,422
Ensembl chr 4:3,503,612...3,532,446
G
LTA
lymphotoxin alpha
no_association susceptibility severity
IAGP EXP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism DNA:SNP:exon:804C>A (p.T26N) (human)
ClinVar OMIM CTD RGD
PMID:12426569 PMID:12746914 PMID:14681301 PMID:15129282 PMID:15266304 PMID:25741868 PMID:15175864 PMID:23398946 PMID:12426569 More...
RGD:1581940 , RGD:8548841 , RGD:1580417
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
treatment
ISO
RGD
PMID:20079142
RGD:11561913
NCBI chr20:34,546,844...34,560,345
Ensembl chr20:34,546,854...34,560,345
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
treatment
ISO
RGD
PMID:22635076
RGD:10412335
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
treatment
ISO
mRNA, protein:increased expression:myocardium (rat)
RGD
PMID:16183734 PMID:27121011
RGD:2298758 , RGD:11073666
NCBI chr 6:90,513,579...90,587,072
Ensembl chr 6:90,513,573...90,587,086
G
MAPK1
mitogen-activated protein kinase 1
ISO
RGD
PMID:15653762
RGD:1582282
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK14
mitogen-activated protein kinase 14
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
G
MAPK8
mitogen-activated protein kinase 8
ameliorates
ISO
RGD
PMID:28622474
RGD:329333030
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MDH2
malate dehydrogenase 2
ISO
RGD
PMID:9753871
RGD:1582468
NCBI chr 7:76,048,106...76,067,508
Ensembl chr 7:76,048,051...76,067,508
G
MDK
midkine
ISO
RGD
PMID:9568069
RGD:1582488
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
G
MEF2A
myocyte enhancer factor 2A
TAS
RGD
PMID:15811259
RGD:1580548
NCBI chr15:99,565,417...99,716,488
Ensembl chr15:99,565,417...99,716,488
G
MEF2C
myocyte enhancer factor 2C
treatment
ISO
RGD
PMID:23948075
RGD:7327215
NCBI chr 5:88,717,117...88,904,105
Ensembl chr 5:88,717,117...88,904,257
G
MEOX2
mesenchyme homeobox 2
ISO
protein:decreased expression:heart (rat)
RGD
PMID:24155330
RGD:155882536
NCBI chr 7:15,611,212...15,686,683
Ensembl chr 7:15,611,212...15,686,683
G
MESP1
mesoderm posterior bHLH transcription factor 1
treatment
IMP
human gene and cell line in a rat model
RGD
PMID:32550911
RGD:242905196
NCBI chr15:89,732,446...89,751,249
Ensembl chr15:89,749,875...89,751,249
G
MFF
mitochondrial fission factor
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23867156 PMID:23867156
RGD:12879458
NCBI chr 2:227,325,251...227,357,836
Ensembl chr 2:227,325,151...227,357,833
G
MFN2
mitofusin 2
treatment
ISO
RGD
PMID:20886221
RGD:12738232
NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211
G
MGP
matrix Gla protein
susceptibility
IAGP
RGD
PMID:11073842
RGD:1582503
NCBI chr12:14,880,864...14,885,854
Ensembl chr12:14,880,864...14,885,857
G
MIA3
MIA SH3 domain ER export factor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198609
NCBI chr 1:222,618,097...222,668,007
Ensembl chr 1:222,618,097...222,668,007
G
MIAT
myocardial infarction associated transcript
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism
CTD OMIM
PMID:17066261
NCBI chr22:26,646,429...26,676,478
Ensembl chr22:26,646,411...26,676,475
G
MIF
macrophage migration inhibitory factor
ISO IEP
mRNA, protein:increased expression:myocardium protein:increased expression:plasma
RGD
PMID:12704210 PMID:11589847
RGD:1642003 , RGD:1642008
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MIR125B2
microRNA 125b-2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29122578
NCBI chr21:16,590,237...16,590,325
Ensembl chr21:16,590,237...16,590,325
G
MIR143
microRNA 143
ISO
RNA:increased expression:myocardium: RNA:increased expression:plasma, left ventricle:
RGD
PMID:28887629 PMID:29728596
RGD:155882580 , RGD:155882581
NCBI chr 5:149,428,918...149,429,023
Ensembl chr 5:149,428,918...149,429,023
G
MIR145
microRNA 145
treatment ameliorates
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29956747 PMID:30146700 PMID:32890431
RGD:155260296 , RGD:155260294
NCBI chr 5:149,430,646...149,430,733
Ensembl chr 5:149,430,646...149,430,733
G
MIR155
microRNA 155
treatment
ISO
RGD
PMID:31207208
RGD:21066347
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR208A
microRNA 208a
treatment
ISO
miRNA:increased expression:heart
RGD
PMID:26688617 PMID:26861724
RGD:11536862 , RGD:242905213
NCBI chr14:23,388,596...23,388,666
Ensembl chr14:23,388,596...23,388,666
G
MIR223
microRNA 223
ISO
RNA:increased expression:heart
RGD
PMID:29608885
RGD:21408565
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
MIR25
microRNA 25
ISO
RNA:increased expression:myocardium:
RGD
PMID:28887629
RGD:155882580
NCBI chr 7:100,093,560...100,093,643
Ensembl chr 7:100,093,560...100,093,643
G
MIR30A
microRNA 30a
treatment
ISO
RGD
PMID:29849775
RGD:35673318
NCBI chr 6:71,403,551...71,403,621
Ensembl chr 6:71,403,551...71,403,621
G
MIR30C1
microRNA 30c-1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:34217758
NCBI chr 1:40,757,284...40,757,372
Ensembl chr 1:40,757,284...40,757,372
G
MIR30E
microRNA 30e
ISO
miRNA:decreased expression:heart (rat)
RGD
PMID:25950484
RGD:11541106
NCBI chr 1:40,754,355...40,754,446
Ensembl chr 1:40,754,355...40,754,446
G
MIR320A
microRNA 320a
treatment
ISO
RGD
PMID:19380620
RGD:155882541
NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043
G
MIR423
microRNA 423
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24253456
NCBI chr17:30,117,079...30,117,172
Ensembl chr17:30,117,079...30,117,172
G
MIR761
microRNA 761
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:23867156
NCBI chr 1:51,836,344...51,836,402
Ensembl chr 1:51,836,344...51,836,402
G
MLXIPL
MLX interacting protein like
susceptibility
IAGP
DNA:SNP:cd: C771G, p.Q241H (rs3812316) (human)
RGD
PMID:24448738
RGD:401799621
NCBI chr 7:73,593,202...73,647,907
Ensembl chr 7:73,593,194...73,624,543
G
MMP1
matrix metallopeptidase 1
susceptibility
IAGP ISO IMP IDA
associated with Coronary Artery Disease; DNA:snps, haplotype:promoter:g.-519A>G, g.-340T>C (human) protein:increased expression, increased activity:heart left ventricle (rat) human gene in rat model
RGD
PMID:16210545 PMID:8531210 PMID:11179039 PMID:19797822 PMID:15009768
RGD:1582520 , RGD:7207198 , RGD:7207136 , RGD:7207135 , RGD:1582535
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP13
matrix metallopeptidase 13
ISO
RGD
PMID:15782494
RGD:1582556
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
G
MMP14
matrix metallopeptidase 14
IDA
RGD
PMID:16461815
RGD:1582569
NCBI chr14:22,836,585...22,847,758
Ensembl chr14:22,836,560...22,849,041
G
MMP2
matrix metallopeptidase 2
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16310260 PMID:24358288 PMID:10773235 PMID:11179039
RGD:1582587 , RGD:7207136
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP3
matrix metallopeptidase 3
IAGP
RGD
PMID:15467919
RGD:1580551
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MMP7
matrix metallopeptidase 7
ISO
RGD
PMID:16769909
RGD:1582373
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
G
MMP9
matrix metallopeptidase 9
susceptibility
ISO EXP IAGP IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:heart left ventricle protein:increased expression, increased activity:heart left ventricle (rat) DNA:snps:promoter, exon:g.-1562C>T, p.R279Q (rs3918242, rs2664538) (human) protein:increased expression:coronary artery, plasma (human)
CTD RGD
PMID:16310260 PMID:24358288 PMID:14729404 PMID:25520329 PMID:8531210 PMID:17893005 PMID:16845718 PMID:15118287 More...
RGD:1582639 , RGD:13204799 , RGD:7207198 , RGD:7207049 , RGD:1582653 , RGD:1582645
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MSTN
myostatin
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 2:190,055,700...190,062,729
Ensembl chr 2:190,055,700...190,062,729
G
MT-ND2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
IAGP
DNA:missense mutation: :m.5178C>A (p.L237M) (human)
RGD
PMID:15262184
RGD:1581054
NCBI chr MT:4,470...5,511
Ensembl chr MT:4,470...5,511
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility
IAGP
associated with Kidney Failure, Chronic; DNA:transition:cds:g.677C>T rs1801133 (human) DNA:SNP: :677C>T (human)
RGD
PMID:19272686 PMID:10090925
RGD:6893548 , RGD:10449412
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
MTOR
mechanistic target of rapamycin kinase
treatment
ISO
protein:decreased serine phosphorylation:heart associated with Diabetes Mellitus, Experimental
RGD
PMID:20352476 PMID:23773982
RGD:10041035 , RGD:10041040
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
MYH6
myosin heavy chain 6
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273
G
MYH7
myosin heavy chain 7
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11743230 PMID:15090263
RGD:11565830
NCBI chr14:23,412,740...23,435,660
Ensembl chr14:23,412,740...23,435,660
G
NCAM1
neural cell adhesion molecule 1
ISO
mRNA, protein:increased expression:heart protein:alternative form, increased expression:myocardium
RGD
PMID:19853610 PMID:23462508
RGD:2325979 , RGD:40924663
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
G
NDUFB5
NADH:ubiquinone oxidoreductase subunit B5
treatment
ISO
RGD
PMID:24692845
RGD:13801194
NCBI chr 3:179,604,794...179,627,647
Ensembl chr 3:179,604,690...179,627,647
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:23290949 PMID:24915518
RGD:10412734 , RGD:10412738
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFKBIA
NFKB inhibitor alpha
treatment
ISO
RGD
PMID:19616538
RGD:10413879
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NGF
nerve growth factor
treatment
IEP IMP
protein:increased expression:myocardium
RGD
PMID:20360245 PMID:20360245
RGD:405100231 , RGD:405100231
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NLK
nemo like kinase
ISO
mRNA, protein:decreased expression:heart
RGD
PMID:26861724
RGD:242905213
NCBI chr17:28,042,677...28,206,074
Ensembl chr17:28,041,737...28,196,381
G
NLRP3
NLR family pyrin domain containing 3
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
G
NONO
non-POU domain containing octamer binding
ameliorates
ISO
RGD
PMID:35247074
RGD:155882458
NCBI chr X:71,283,635...71,301,168
Ensembl chr X:71,254,814...71,301,522
G
NOS2
nitric oxide synthase 2
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10090345 PMID:11489778 PMID:26192027
RGD:329970290
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
susceptibility treatment
IAGP EXP ISO IMP
DNA:repeats:intron CTD Direct Evidence: marker/mechanism protein:decreased expression:aorta (rat) human gene in rat model DNA:duplication:intron:IVS4?-?+27 (human)
CTD RGD
PMID:10510054 PMID:16337503 PMID:10531147 PMID:29311930 PMID:28980197 PMID:22012955 PMID:17637430 PMID:12362496 PMID:11903359 More...
RGD:5128481 , RGD:13503346 , RGD:13450930 , RGD:7771563 , RGD:7771561 , RGD:1580283 , RGD:1580284
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NPM1
nucleophosmin 1
ISO
protein:increased expression:cardiomyocyte:
RGD
PMID:21444791
RGD:11535018
NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
G
NPPA
natriuretic peptide A
IAGP EXP ISO
DNA:snp:cds:c.2238T>C (human) CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:9527094 PMID:11743230 PMID:12514664 PMID:16087130
RGD:1579982 , RGD:1580000
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
G
NPPB
natriuretic peptide B
ISO IDA
RGD
PMID:19858735 PMID:17639095 PMID:17256064
RGD:2324680 , RGD:7247724 , RGD:1642266
NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
G
NPR1
natriuretic peptide receptor 1
susceptibility
IAGP
DNA:missense mutation:cds:p.M341I (human)
RGD
PMID:14646971
RGD:1580174
NCBI chr 1:153,678,688...153,693,992
Ensembl chr 1:153,678,688...153,693,992
G
NR1H3
nuclear receptor subfamily 1 group H member 3
susceptibility
IAGP
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
RGD
PMID:21903943
RGD:401842365
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
NR3C2
nuclear receptor subfamily 3 group C member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16413583 PMID:17587755
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
G
NRG1
neuregulin 1
treatment
IDA
RGD
PMID:24200746 PMID:27993643
RGD:10449026 , RGD:405145704
NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
G
NRIP1
nuclear receptor interacting protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22503866
NCBI chr21:14,961,235...15,065,936
Ensembl chr21:14,961,235...15,065,936
G
OLR1
oxidized low density lipoprotein receptor 1
susceptibility
IAGP EXP
DNA:missense mutation:cds:p.K167N (human) ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD RGD
PMID:12646194 PMID:12810610 PMID:14684693 PMID:25741868 PMID:12646194
RGD:1580996
NCBI chr12:10,158,301...10,176,266
Ensembl chr12:10,158,301...10,172,138
G
OPA1
OPA1 mitochondrial dynamin like GTPase
treatment
ISO
RGD
PMID:20886221
RGD:12738232
NCBI chr 3:193,593,208...193,697,811
Ensembl chr 3:193,593,144...193,697,811
G
OPRD1
opioid receptor delta 1
ISO
RGD
PMID:12798419 PMID:15076225
RGD:2316587 , RGD:9831425
NCBI chr 1:28,812,170...28,871,267
Ensembl chr 1:28,812,170...28,871,267
G
OPRK1
opioid receptor kappa 1
ISO
RGD
PMID:15076225
RGD:9831425
NCBI chr 8:53,225,724...53,251,637
Ensembl chr 8:53,225,724...53,251,637
G
P2RY12
purinergic receptor P2Y12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19334620
NCBI chr 3:151,336,843...151,384,753
Ensembl chr 3:151,336,843...151,384,753
G
PAPPA
pappalysin 1
susceptibility
IAGP EXP
DNA:polymorphism:intron CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11586954 PMID:17700210
RGD:1642324
NCBI chr 9:116,153,791...116,402,321
Ensembl chr 9:116,153,791...116,402,321
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
protein:altered processing:left ventricle (mouse)
RGD
PMID:21282286
RGD:5684012
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PCSK2
proprotein convertase subtilisin/kexin type 2
IAGP
DNA:SNP:intron: (rs6080699) (human)
RGD
PMID:20036365
RGD:6483554
NCBI chr20:17,226,107...17,484,578
Ensembl chr20:17,226,107...17,484,578
G
PDE3A
phosphodiesterase 3A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr12:20,368,537...20,688,583
Ensembl chr12:20,368,537...20,688,583
G
PDE5A
phosphodiesterase 5A
ISO
RGD
PMID:17339532
RGD:2314468
NCBI chr 4:119,494,403...119,628,804
Ensembl chr 4:119,494,397...119,628,804
G
PDGFD
platelet derived growth factor D
ISO
mRNA,protein:altered expression:myocardium:
RGD
PMID:21767547
RGD:9854703
NCBI chr11:103,907,189...104,164,147
Ensembl chr11:103,907,189...104,164,379
G
PEBP1
phosphatidylethanolamine binding protein 1
ISO
protein:decreased expression:right heart ventricle, ventricular septum
RGD
PMID:17089028
RGD:2302667
NCBI chr12:118,136,124...118,145,584
Ensembl chr12:118,136,124...118,145,584
G
PECAM1
platelet and endothelial cell adhesion molecule 1
onset no_association
IAGP
DNA:polymorphisms: :p.N563S, p.G670R (human) DNA:missense mutation:cds:p.R643G (human) DNA:missense mutations:cds:p.L125V, p.S563N (human)
RGD
PMID:11795274 PMID:15488875 PMID:15265022
RGD:2311656 , RGD:6771224 , RGD:1581009
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PGF
placental growth factor
ISO IDA
RGD
PMID:20649603 PMID:21329947 PMID:22114497
RGD:6483584 , RGD:6483777 , RGD:6483773
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
G
PHACTR1
phosphatase and actin regulator 1
susceptibility severity no_association
EXP IAGP IEP ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:intron: (rs9369640) (human) DNA:SNPs:multiple (human) DNA:SNP:intron:(rs12526453) (human) mRNA:increased expression:peripheral blood mononuclear cells (human) DNA:SNPs:intron 3: (rs9349379, rs2026458, rs2876300) (human) DNA:SNP:intron:g.13035530G>C (rs12526453) (human) mRNA, protein:decreased expression:heart left ventricle (rat)
CTD RGD
PMID:19198609 PMID:26098115 PMID:25738804 PMID:25838425 PMID:26086777 PMID:33460763 PMID:33460763 PMID:19198609 PMID:26098115 More...
RGD:11052994 , RGD:11052493 , RGD:11056926 , RGD:401900171 , RGD:401900171 , RGD:401851907 , RGD:11053274
NCBI chr 6:12,716,767...13,287,837
Ensembl chr 6:12,716,312...13,290,446
G
PHLDA3
pleckstrin homology like domain family A member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34351043
NCBI chr 1:201,464,278...201,469,188
Ensembl chr 1:201,464,278...201,469,237
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:20056919
RGD:6482688
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
G
PLA2G7
phospholipase A2 group VII
IEP
protein:decreased expression:serum
RGD
PMID:19644070
RGD:6482786
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
PLAT
plasminogen activator, tissue type
treatment
IAGP EXP IDA
DNA:snp:enhancer:g.-7351C>T (human) CTD Direct Evidence: therapeutic
CTD RGD
PMID:1430592 PMID:1492007 PMID:1898952 PMID:1899364 PMID:1900011 PMID:2104561 PMID:2105625 PMID:2494454 PMID:2505604 PMID:2521976 PMID:3089627 PMID:3121335 PMID:7488445 PMID:7723950 PMID:7775709 PMID:7902905 PMID:8328192 PMID:8554022 PMID:8598594 PMID:9183334 PMID:10171637 PMID:10505926 PMID:10645301 PMID:10914357 PMID:11382373 PMID:11489769 PMID:12074692 PMID:12227717 PMID:12848087 PMID:15215796 PMID:15301905 PMID:18195371 PMID:19341228 PMID:20122609 PMID:11848437 PMID:7994806 More...
RGD:1580881 , RGD:11541077
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
PLAU
plasminogen activator, urokinase
IAGP EXP IMP ISO
DNA:SNP:3' utr:c.*141C>T (rs4065) (human) CTD Direct Evidence: marker/mechanism|therapeutic mRNA, protein:increased expression:myocardium
CTD RGD
PMID:1908371 PMID:2174952 PMID:2382605 PMID:3068399 PMID:3984876 PMID:8416330 PMID:20518747 PMID:17653104 PMID:20952728 More...
RGD:6484126 , RGD:6484145 , RGD:6484133
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PLAUR
plasminogen activator, urokinase receptor
IEP ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:12393744 PMID:20952728
RGD:1580897 , RGD:6484133
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PLCB1
phospholipase C beta 1
ISO
protein:increased expression:heart
RGD
PMID:9521338
RGD:2314514
NCBI chr20:8,132,266...8,884,900
Ensembl chr20:8,077,251...8,968,360
G
PLCB3
phospholipase C beta 3
ISO
protein:increased expression:heart
RGD
PMID:9521338
RGD:2314514
NCBI chr11:64,251,530...64,269,452
Ensembl chr11:64,251,530...64,269,150
G
PLN
phospholamban
treatment
ISO EXP
protein:decreased expression:heart left ventricle (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16026515 PMID:16162791 PMID:23781262 PMID:26067684
RGD:7327176 , RGD:11097969
NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
G
PON1
paraoxonase 1
IAGP
RGD
PMID:10978258 PMID:10610741
RGD:1580202 , RGD:1580198
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
POSTN
periostin
ISO
protein:increased expression:heart:
RGD
PMID:24212842
RGD:10041024
NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
G
PPARA
peroxisome proliferator activated receptor alpha
IAGP
DNA:SNP:intron:rs4253623, minor allele associated with increased risk
RGD
PMID:18549840
RGD:5562819
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARGC1A
PPARG coactivator 1 alpha
IEP EXP ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:heart
CTD RGD
PMID:22503866 PMID:22087236 PMID:22503866
RGD:6484266 , RGD:7242181
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
G
PRKCE
protein kinase C epsilon
EXP ISO
CTD Direct Evidence: therapeutic RNA:decreased expression:myocardium:
CTD RGD
PMID:16782078 PMID:28887629
RGD:155882580
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
G
PRKD1
protein kinase D1
treatment
ISO
RGD
PMID:26064267
RGD:289474908
NCBI chr14:29,576,479...29,927,847
Ensembl chr14:29,576,479...30,191,898
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
IEP
RGD
PMID:10936861
RGD:11100014
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
G
PRORP-PSMA6
PRORP-PSMA6 readthrough
IAGP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar
PMID:16845397 PMID:19282875 PMID:25741868
NCBI chr14:35,121,839...35,317,471
G
PSMA6
proteasome 20S subunit alpha 6
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:16845397 PMID:19282875 PMID:25741868
NCBI chr14:35,278,558...35,317,493
Ensembl chr14:35,278,633...35,317,493
G
PTGIS
prostaglandin I2 synthase
susceptibility
IAGP
DNA:SNP::1117C>A (human) DNA:silent mutation:exon 8:1117C>A (human) DNA:SNP:CDS: (rs5629) (human)
RGD
PMID:19040046 PMID:12040339 PMID:19327107 PMID:19046748
RGD:401901147 , RGD:401901268 , RGD:401901155 , RGD:2313891
NCBI chr20:49,503,874...49,568,137
Ensembl chr20:49,503,874...49,568,137
G
PTGS2
prostaglandin-endoperoxide synthase 2
IAGP
RGD
PMID:15138244
RGD:1581289
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTN
pleiotrophin
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:17925408
RGD:10044023
NCBI chr 7:137,227,341...137,343,733
Ensembl chr 7:137,227,341...137,343,774
G
RAD50
RAD50 double strand break repair protein
treatment
ISO
RGD
PMID:15623426
RGD:9831390
NCBI chr 5:132,556,977...132,646,349
Ensembl chr 5:132,556,019...132,646,349
G
RANBP1
RAN binding protein 1
ISO
protein:decreased expression:heart ventricle, cytoplasm (rat)
RGD
PMID:25341891
RGD:9835001
NCBI chr22:20,116,104...20,127,355
Ensembl chr22:20,115,938...20,127,355
G
RBP4
retinol binding protein 4
IEP
protein:increased expression:blood serum (human)
RGD
PMID:25142320
RGD:329845867
NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744
G
REG1A
regenerating family member 1 alpha
ISO
mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:15778284
RGD:9850130
NCBI chr 2:79,120,488...79,123,409
Ensembl chr 2:79,120,362...79,123,409
G
REN
renin
susceptibility
IEP EXP
associated with Hypertension; protein:increased activity:plasma (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:1668233 PMID:1759997
RGD:6892687
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
G
RETN
resistin
IEP
protein:increased expression:plasma
RGD
PMID:18997620
RGD:7207152
NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455
G
RPS6KB1
ribosomal protein S6 kinase B1
ISO
protein:increased threonine phosphorylation:heart left ventricle
RGD
PMID:16540832
RGD:1642998
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
G
RYR1
ryanodine receptor 1
ISO
protein:hyperphosphorylation:extensor digitorum longus:
RGD
PMID:12824280
RGD:329813076
NCBI chr19:38,433,691...38,587,564
Ensembl chr19:38,433,691...38,595,273
G
S100B
S100 calcium binding protein B
ISO EXP
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9788975 PMID:19910580
RGD:2325647
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
G
SDC1
syndecan 1
ISO
mRNA:increased expression:myocardium
RGD
PMID:9237025
RGD:2311712
NCBI chr 2:20,200,797...20,225,475
Ensembl chr 2:20,200,797...20,225,433
G
SDC4
syndecan 4
IEP
protein:increased expression:plasma
RGD
PMID:11372670
RGD:2312328
NCBI chr20:45,325,288...45,348,424
Ensembl chr20:45,325,288...45,348,424
G
SELL
selectin L
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:10070497
NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702
G
SELP
selectin P
susceptibility
IEP ISO IAGP
associated with Hypertension;protein:increased expression:plasma protein:increased expression:serum DNA:polymorphisms, haplotypes:cds:p.S290N, p.N562D, p.T715P (human)
RGD
PMID:17391113 PMID:21162967 PMID:21567088 PMID:12165563
RGD:2312304 , RGD:6219003 , RGD:6218991 , RGD:1580075
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
SERPINE1
serpin family E member 1
susceptibility
IAGP ISO
DNA:deletion:promoter:g.-676_-674delG (human)
RGD
PMID:12477941 PMID:16053971
RGD:1626626 , RGD:8547882
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SFRP2
secreted frizzled related protein 2
ISO
RGD
PMID:19109969 PMID:19079247
RGD:4107088 , RGD:155883169
NCBI chr 4:153,780,591...153,789,083
Ensembl chr 4:153,780,591...153,789,083
G
SH2B3
SH2B adaptor protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198610
NCBI chr12:111,404,730...111,451,623
Ensembl chr12:111,405,923...111,451,623
G
SHH
sonic hedgehog signaling molecule
treatment
ISO
RGD
PMID:20052412
RGD:12879408
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
G
SIRT1
sirtuin 1
ISO
protein:altered localization:nucleus
RGD
PMID:20089851
RGD:2316169
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
SIRT3
sirtuin 3
treatment
ISO
RGD
PMID:24471974
RGD:9586050
NCBI chr11:215,030...236,931
Ensembl chr11:215,030...236,931
G
SLC27A1
solute carrier family 27 member 1
ISO
protein:decreased expression:heart
RGD
PMID:17034771
RGD:1642800
NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168
G
SLC27A6
solute carrier family 27 member 6
ISO
protein:decreased expression:heart
RGD
PMID:17034771
RGD:1642800
NCBI chr 5:128,965,488...129,033,635
Ensembl chr 5:128,538,013...129,033,642
G
SLPI
secretory leukocyte peptidase inhibitor
treatment
ISO
RGD
PMID:23361363
RGD:9999400
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
G
SMAD2
SMAD family member 2
treatment ameliorates
ISO
RGD
PMID:11087260 PMID:33409963
RGD:12903276 , RGD:401794430
NCBI chr18:47,808,957...47,930,872
Ensembl chr18:47,808,957...47,931,146
G
SMAD3
SMAD family member 3
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
G
SMAD4
SMAD family member 4
treatment
ISO
RGD
PMID:11087260
RGD:12903276
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
G
SOCS1
suppressor of cytokine signaling 1
ISO
protein:increased expression:heart
RGD
PMID:16377761
RGD:2298918
NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
G
SOD1
superoxide dismutase 1
treatment
ISO EXP IMP
CTD Direct Evidence: therapeutic human gene in a rat model
CTD RGD
PMID:21600015 PMID:11864929 PMID:22006090
RGD:1581222 , RGD:8655953
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
IEP EXP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12160945 PMID:2313102 PMID:9250167 PMID:14575298
RGD:1580840 , RGD:1580839 , RGD:1581148
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SOD3
superoxide dismutase 3
IDA IEP
RGD
PMID:14592844 PMID:14592844
RGD:1580841 , RGD:1580841
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
G
SPARC
secreted protein acidic and cysteine rich
ISO
mRNA:increased expression:heart
RGD
PMID:12826287
RGD:2300056
NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975
G
SPP1
secreted phosphoprotein 1
IDA ISO
RGD
PMID:12939547 PMID:14500723
RGD:1581386 , RGD:1581325
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SRSF1
serine and arginine rich splicing factor 1
treatment
ISO
protein:increased phosphorylation:heart left ventricle(rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr17:57,989,038...58,007,246
Ensembl chr17:58,000,919...58,007,346
G
TBX3
T-box transcription factor 3
ISO
RGD
PMID:19341743
RGD:5132891
NCBI chr12:114,670,255...114,684,175
Ensembl chr12:114,670,255...114,684,175
G
TBX5
T-box transcription factor 5
treatment
ISO
RGD
PMID:23948075
RGD:7327215
NCBI chr12:114,353,911...114,408,442
Ensembl chr12:114,353,911...114,408,442
G
TEK
TEK receptor tyrosine kinase
ISO
protein:increased expression:ventricle myocardium
RGD
PMID:16714360
RGD:1601493
NCBI chr 9:27,109,141...27,230,178
Ensembl chr 9:27,109,141...27,230,174
G
TFPI
tissue factor pathway inhibitor
treatment
IDA ISO IEP
mRNA,protein:increased expression:heart:
RGD
PMID:15630488 PMID:21229253 PMID:14656922
RGD:11060131 , RGD:11062083 , RGD:11060139
NCBI chr 2:187,464,230...187,554,435
Ensembl chr 2:187,464,230...187,565,760
G
TGFB1
transforming growth factor beta 1
susceptibility
IAGP EXP ISO IEA
associated with Coronary Disease;DNA:polymorphism:promoter:-509C>T (human) CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:heart:
CTD RGD
PMID:16310260 PMID:16543493 PMID:27121011 PMID:15118671
RGD:1601560 , RGD:11073666 , RGD:1331525
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFB2
transforming growth factor beta 2
ISO
RGD
PMID:14575314
RGD:2302107
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
G
TGFBR1
transforming growth factor beta receptor 1
ISO
RGD
PMID:10198196
RGD:1601617
NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192
G
TGFBR2
transforming growth factor beta receptor 2
ISO
RGD
PMID:10198196
RGD:1601617
NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,601...30,694,142
G
TH
tyrosine hydroxylase
no_association
IAGP
DNA:polymorphism:intron:g.1170_1173dupTCAT (human)
RGD
PMID:16139102
RGD:1580048
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
G
THBD
thrombomodulin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9843165 PMID:10627464
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
THBS1
thrombospondin 1
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:16179730
RGD:2317960
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
G
TIMP2
TIMP metallopeptidase inhibitor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
G
TLR4
toll like receptor 4
IAGP
DNA:SNP:intron:rs1927911, minor allele associated with decreased risk
RGD
PMID:15864121 PMID:18549840
RGD:1580734 , RGD:5562819
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TM6SF2
transmembrane 6 superfamily member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24633158
NCBI chr19:19,264,366...19,273,301
Ensembl chr19:19,264,364...19,273,391
G
TNC
tenascin C
ISO
protein:increased expression:heart, fibroblast
RGD
PMID:11454990
RGD:4889618
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNF
tumor necrosis factor
ISO EXP
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15883752 PMID:16310260 PMID:21362018
RGD:5130892
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFRSF11B
TNF receptor superfamily member 11b
IEP
RGD
PMID:15926884
RGD:1620893
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
G
TNFRSF12A
TNF receptor superfamily member 12A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20082609
NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383
G
TNFRSF14
TNF receptor superfamily member 14
ISO
protein:increased expression:heart, cardiomyocyte, endothelial cell (rat)
RGD
PMID:18353719
RGD:2317281
NCBI chr 1:2,554,234...2,563,829
Ensembl chr 1:2,555,639...2,565,382
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
mRNA, protein:increased expression:left ventricle myocardium (rat)
RGD
PMID:15117889 PMID:20651834 PMID:21362018
RGD:1624194 , RGD:5130975 , RGD:5130892
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
mRNA, protein:decreased expression:left ventricle myocardium (rat)
RGD
PMID:21362018
RGD:5130892
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
G
TNFSF11
TNF superfamily member 11
IEP
protein:increased expression:serum
RGD
PMID:18298349
RGD:2302363
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
G
TNFSF4
TNF superfamily member 4
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:15750594
RGD:1580396
NCBI chr 1:173,172,870...173,450,733
Ensembl chr 1:173,183,731...173,207,331
G
TNNI3
troponin I3, cardiac type
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12359538
NCBI chr19:55,151,767...55,157,732
Ensembl chr19:55,151,767...55,157,773
G
TNNT2
troponin T2, cardiac type
IEP
RGD
PMID:15226628
RGD:1580441
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TREM1
triggering receptor expressed on myeloid cells 1
ameliorates disease_progression
ISO IEP
RGD
PMID:25840803 PMID:25840803 PMID:25840803
RGD:127284842 , RGD:127284842 , RGD:127284842
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
TRPV1
transient receptor potential cation channel subfamily V member 1
ISO
RGD
PMID:27671317
RGD:13792689
NCBI chr17:3,565,446...3,609,411
Ensembl chr17:3,565,444...3,609,411
G
TTN
titin
ISO
RGD
PMID:12221049
RGD:1580780
NCBI chr 2:178,525,989...178,807,423
Ensembl chr 2:178,525,989...178,830,802
G
TXN
thioredoxin
IEP
RGD
PMID:14677813
RGD:1580785
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
TXNRD1
thioredoxin reductase 1
ISO
mRNA:decreased expression:heart left ventricle (rat)
RGD
PMID:18515646
RGD:5134341
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
UBD
ubiquitin D
ISO
mRNA, protein; increased expression; myocardium (rat)
RGD
PMID:29438664
RGD:126925221
NCBI chr 6:29,555,515...29,559,732
Ensembl chr 6:29,555,515...29,559,732
G
UTS2
urotensin 2
ISO
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
RGD
PMID:15549273
RGD:2306846
NCBI chr 1:7,847,612...7,913,249
Ensembl chr 1:7,843,083...7,853,512
G
UTS2R
urotensin 2 receptor
ISO
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
RGD
PMID:15549273
RGD:2306846
NCBI chr17:82,371,765...82,377,458
Ensembl chr17:82,371,765...82,377,458
G
VCAN
versican
ISO
RGD
PMID:16311904
RGD:1598497
NCBI chr 5:83,471,744...83,582,302
Ensembl chr 5:83,471,618...83,582,303
G
VDAC1
voltage dependent anion channel 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25488258
NCBI chr 5:133,971,871...134,114,540
Ensembl chr 5:133,971,871...134,004,975
G
VDAC2
voltage dependent anion channel 2
treatment
ISO
RGD
PMID:20601275
RGD:10003049
NCBI chr10:75,210,170...75,231,448
Ensembl chr10:75,210,154...75,231,448
G
VEGFA
vascular endothelial growth factor A
treatment
IEP ISO
protein:increased expression:serum,platelet:
RGD
PMID:10652191 PMID:25936512
RGD:7483604 , RGD:126925214
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VEGFB
vascular endothelial growth factor B
IMP
RGD
PMID:17975666
RGD:2314324
NCBI chr11:64,234,584...64,239,264
Ensembl chr11:64,234,584...64,239,264
G
VWF
von Willebrand factor
ISO
protein:increased expression:heart:
RGD
PMID:19435557
RGD:11080745
NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770
G
WDR12
WD repeat domain 12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198609 PMID:25915632
NCBI chr 2:202,874,261...202,911,673
Ensembl chr 2:202,874,261...203,014,798
G
WRN
WRN RecQ like helicase
IAGP
RGD
PMID:9021029
RGD:1580821
NCBI chr 8:31,033,810...31,176,138
Ensembl chr 8:31,033,788...31,176,138
G
XRCC3
X-ray repair cross complementing 3
susceptibility
IAGP
DNA:polymorphism:: (human)
RGD
PMID:18712175
RGD:401827276
NCBI chr14:103,697,617...103,715,451
Ensembl chr14:103,697,609...103,715,504
G
YBX1
Y-box binding protein 1
ISO
RGD
PMID:16002047
RGD:1580630
NCBI chr 1:42,682,418...42,703,805
Ensembl chr 1:42,682,418...42,703,805
G
ZEB2
zinc finger E-box binding homeobox 2
ISO
protein:increased expression:heart (rat)
RGD
PMID:24155330
RGD:155882536
NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16317512
NCBI chr12:110,280,616...110,351,093
Ensembl chr12:110,280,756...110,351,093
G
NOS2
nitric oxide synthase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11927517
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
PLN
phospholamban
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16317512
NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:11927517
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
CDH5
cadherin 5
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784
G
CTNNB1
catenin beta 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
JUP
junction plakoglobin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr17:41,754,609...41,786,711
Ensembl chr17:41,754,604...41,786,931
G
ICAM1
intercellular adhesion molecule 1
IEP
protein:increased expression:plasma
RGD
PMID:9415270
RGD:8547713
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
KCNJ8
potassium inwardly rectifying channel subfamily J member 8
ISO
RGD
PMID:11984590
RGD:1581700
NCBI chr12:21,764,955...21,774,706
Ensembl chr12:21,764,955...21,775,600
G
ABCB1
ATP binding cassette subfamily B member 1
treatment
IAGP
DNA:SNPs: :rs1045642,rs7779562(human)
RGD
PMID:25217066
RGD:14700903
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ATP5MC2
ATP synthase membrane subunit c locus 2
severity
IEP
RGD
PMID:27441480
RGD:14696800
NCBI chr12:53,665,170...53,681,423
Ensembl chr12:53,632,726...53,677,408
G
CCN1
cellular communication network factor 1
sexual_dimorphism
IEP
protein:increased expression:blood serum (human)
RGD
PMID:34597881
RGD:329845519
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
LGALS3
galectin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29769800
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
G
MIR208A
microRNA 208a
severity
ISO
miRNA:increased expression:blood
RGD
PMID:32458401
RGD:213230165
NCBI chr14:23,388,596...23,388,666
Ensembl chr14:23,388,596...23,388,666
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all